[{"status": "Terminated", "city": "Tlalnepantla", "state": "N/A", "country": "Mexico", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86037", "recalling_firm": "AAA Cosmetica, SA de CV", "address_1": "Calle Recursos Hidraulicos 1", "address_2": "Pueblo La Loma, Tlalnepantla De Baz", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-1569-2020", "product_description": "bio aaa Advance Hand Sanitizer Ethyl Alcohol 70%, Unscented, 16.23 Oz (480 mL), Distributed By: Payless Janitorial Corporation 1341 SW 21 Terrance, Fort Lauderdale, Florida  Exported By: E. Audicode S.A. de C.V. Manufactured By: AAA Cosmetica S.A. de C.V.  UPC  7 502272 12111 5", "product_quantity": "21,228  bottles", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20200702", "center_classification_date": "20200911", "termination_date": "20240116", "report_date": "20200909", "code_info": "Lots:  All lots to include 20DF9005, 20DF9006, EXP April 2022"}, {"status": "Terminated", "city": "Brookhaven", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88997", "recalling_firm": "Amneal Pharmaceuticals of New York, LLC", "address_1": "50 Horseblock Rd", "address_2": "N/A", "postal_code": "11719-9509", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide within the United States", "recall_number": "D-0234-2022", "product_description": "Flocinolone Acetonide 0.01% Topical Oil, Scalp Oil, Rx, packaged in 4 oz. bottle, Distributed by: Amneal Pharmaceuticals Bridgewater, NJ 08807, NDC 65162-703-86", "product_quantity": "15,88 bottles", "reason_for_recall": "Subpotent Drug: Out-of-specification assay result was obtained for Fluocinolone Acetonide.", "recall_initiation_date": "20211104", "center_classification_date": "20211116", "termination_date": "20220609", "report_date": "20211124", "code_info": "Lot #: 07030002A, exp. date 02/2022", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; ZOLPIDEM TARTRATE Tablet, 2.5 mg (1/2 of 5 mg) may be potentially mislabeled as    TEMAZEPAM, Capsule, 7.5 mg, NDC 00378311001, Pedigree: AD22861_7, EXP: 5/8/2014.", "address_2": "", "product_quantity": "402 Tablets", "code_info": "ZOLPIDEM TARTRATE Tablet, 2.5 mg (1/2 of 5 mg) has the following code    Pedigree: AD28355_1, EXP: 5/8/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "ZOLPIDEM TARTRATE, Tablet, 2.5 mg (1/2 of 5 mg), Rx only, Distributed by: AidaPak Service, LLC, NDC 64679071401", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-691-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Noblesville", "address_1": "14450 Getz Rd", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "1925", "code_info": "All Sterile Compounded Products within Expiry", "center_classification_date": "20160711", "distribution_pattern": "Nationwide        VA/DOD: CA, KY, MD, NC, OK, TX, VA", "state": "IN", "product_description": "Rocuronium 10 mg/mL, 5 mL syringe, Rx Only, Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN 46060, NDC  45183-0955-70", "report_date": "20160720", "classification": "Class II", "openfda": {}, "recalling_firm": "Pharmakon Pharmaceuticals, Inc.", "recall_number": "D-1333-2016", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "73960", "termination_date": "20180111", "more_code_info": "", "recall_initiation_date": "20160420", "postal_code": "46060-3303", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Asheville", "address_1": "752 Biltmore Ave", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "address_2": "", "product_quantity": "", "code_info": "All lot numbers within expiry.", "center_classification_date": "20140304", "distribution_pattern": "NC", "state": "NC", "product_description": "Acetylcysteine 10% ophthalmic", "report_date": "20140312", "classification": "Class II", "openfda": {}, "recalling_firm": "Natures Pharmacy & Compounding Center", "recall_number": "D-1099-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "66856", "termination_date": "20140424", "more_code_info": "", "recall_initiation_date": "20131101", "postal_code": "28803-2558", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0193-2022", "product_description": "TRI-MIX PAPAVERINE 20/PHENTOLAMINE 1/PGE-1 20 INJ   INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "1 vial", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: 07282021:66 BUD: 11/30/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Hazelwood", "state": "MO", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "62696", "recalling_firm": "Mallinckrodt Inc", "address_1": "675 James S McDonnell Blvd", "address_2": "N/A", "postal_code": "63042-2301", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "FAX", "distribution_pattern": "AZ, CT, MO, MS, PA, FL, WA, NC, CA, TX, OK", "recall_number": "D-1692-2012", "product_description": "Thallous Chloride Tl 201 Injection, Diagnostic Sterile, Non-Pyrogenic Solution, a) 2.8 mL (NDC 0019N12028) b) 6.3ml (NDC 0019N12063) For Intravenous Administration, each milliliter contains 37 MBq (1 mCi) Thallous Chloride Tl 201 (no carrier added) at date and time of calibration, 9 mg sodium chloride and 0.9% (v/v) benzyl alcohol as a preservative, RX, Mallinckrodt Inc., St. Louis, MO 63134", "product_quantity": "12/2.8mCi-vials and 12/6.3mCi-vials", "reason_for_recall": "Labeling: Correct Labeled Product Miscart/Mispack: labels on outer containers do not match labels on vials (the correct label)", "recall_initiation_date": "20120730", "center_classification_date": "20120925", "termination_date": "20121116", "report_date": "20121003", "code_info": "Lot 120-2686, exp. 8/2/12.", "more_code_info": ""}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-254-2014", "product_description": "Poison Ivy Extract 10ml, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "45 units", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"status": "Terminated", "city": "Farmingdale", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA091239"], "brand_name": ["IBUPROFEN"], "generic_name": ["IBUPROFEN"], "manufacturer_name": ["TIME CAP LABORATORIES,INC"], "product_ndc": ["49483-114", "49483-601", "49483-600"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["IBUPROFEN"], "rxcui": ["310965"], "spl_id": ["375d8923-4e92-d631-e063-6294a90a20eb"], "spl_set_id": ["f58d35f9-e44b-417b-98ce-0766b537cd2f"], "package_ndc": ["49483-114-50", "49483-114-10", "49483-114-17", "49483-114-73", "49483-601-00", "49483-601-05", "49483-601-01", "49483-601-50", "49483-601-10", "49483-600-05", "49483-600-01", "49483-600-50", "49489-601-10"], "is_original_packager": [true], "upc": ["0349483600018", "0349483601015", "0349483600056", "0349483114171", "0349483600506"], "nui": ["N0000000160", "M0001335", "N0000175722"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "unii": ["WK2XYI10QM"]}, "product_type": "Drugs", "event_id": "79349", "recalling_firm": "Time-Cap Laboratories, Inc.", "address_1": "7 Michael Ave", "address_2": "N/A", "postal_code": "11735-3921", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-0685-2018", "product_description": "Ibuprofen Tablets, USP, 200 mg, a) 50 tablets (NDC 49483-601-05), b) 100 tablets (NDC- 49483-601-01), c) 500 tablets (NDC 49483-601-50), d) 1000 tablets  (NDC 49489-601-10), e) Bulk (49483-601-00) bottles, Brown, Manufactured for: Time Cap Labs, Inc., Farmingdale, NY 11735, Manufactured by: Marksans Pharma, Ltd., Verna, Goa-403 722, India", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.", "recall_initiation_date": "20180111", "center_classification_date": "20180422", "termination_date": "20210120", "report_date": "20180502", "code_info": "a) D167C, exp 2/18;     b) D172C, exp 2/18, H057C, exp 6/18;     c) D164C, exp 2/18, E135C, exp 3/18;     d) D172C, exp 2/18,  E135C, exp 3/18, F004C, exp 5/18;     e)  D175C, D176C,   D177C,   D178C,   D179C,   D180C,   D162C,   D163C,   D164C,   D165C,   D166C,   D168C,   D169C,   D170C,   D171C,   D173C,   E104C,   E105C,   D191C,   D192C,   D193C,   D194C,   D195C,   D196C,   D197C,   D198C,   D199C,   D200C,   D201C,   E106C, exp 2/18;   L111C,   F005C,   F006C,   F007C,   F008C,   H053C,   H054C,   H055C,   H056C, exp 5/18;   L112C,   L113C,   L114C,   L115C,   L116C,   L117C,   L118C,   L119C,   J008C,   J009C,   H057C,   H058C, exp 6/18;   L120C,   L121C,   L122C,   L123C,   L124C, exp 8/18"}, {"status": "Terminated", "city": "Northfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78575", "recalling_firm": "Medline Industries Inc", "address_1": "Three Lakes Drive", "address_2": "", "postal_code": "60093", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA, Puerto Rico, China, Chile, Guam, Honduras, India, Israel, Malaysia, Mexico, Turkey", "recall_number": "D-0288-2018", "product_description": "Medline NICC Suture Removal Tray, Sterile, Single Use Only. Packaged in Mexico for Medline Industries, Inc., Mundelein, IL 60060", "product_quantity": "346 cases", "reason_for_recall": "Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads  is below label claim of 0.85%.", "recall_initiation_date": "20170921", "center_classification_date": "20180204", "termination_date": "20230828", "report_date": "20180207", "code_info": "Pack Number: DYNDR1161; Lots: 17RB9449    Pack Number: DYNDR1161H; Lots: 17RB9449", "more_code_info": ""}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "1 unit", "code_info": "Rx #:   0392313", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "CYCLOPENT/LIDOCAINE/PHENYLEPHRINE/TROPICAMIDE 0.5%/0.5%/0.625%/0.25% OPHTHALMIC 20 ML (1 PRODUCT)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1491-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA202867"], "brand_name": ["MOXIFLOXACIN"], "generic_name": ["MOXIFLOXACIN"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "product_ndc": ["68180-422"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["MOXIFLOXACIN HYDROCHLORIDE MONOHYDRATE"], "rxcui": ["403818"], "spl_id": ["40262fef-9713-4538-b96b-c44b257d6a25"], "spl_set_id": ["ae77e219-8af9-4aa4-96d3-05c9726a1d3c"], "package_ndc": ["68180-422-01"], "is_original_packager": [true], "upc": ["0368180422013"], "unii": ["B8956S8609"]}, "product_type": "Drugs", "event_id": "82037", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "111 S Calvert St Fl 21ST", "address_2": "N/A", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed by 5 wholesalers, 6 drug chains, 4 mail order pharmacies and 1 mail order pharmacy/supermarket who may have further distribute the product throughout the United States.", "recall_number": "D-0484-2019", "product_description": "Moxifloxacin Ophthalmic Solution USP, 0.5%, 3 mL dropper bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 Manufactured by: lupin Limited Pithampur (M.P.) 454 775 India. NDC 68180-422-01", "product_quantity": "43,860 3ml  bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: Out of specification test results in related substance at three-month long term stability study was obtained.", "recall_initiation_date": "20190201", "center_classification_date": "20190208", "termination_date": "20200626", "report_date": "20190220", "code_info": "Lot Numbers: H705562, H705563, EXP. 11/2019; H800616, EXP. 01/2020"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "1 unit", "code_info": "Rx #:    0401630", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "PANTOTHENIC ACID 1MG/ML INJECTABLE\t30 ML  (1 PRODUCT)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1592-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "63488", "recalling_firm": "Valeant Pharmaceuticals", "address_1": "700 Rte 206 North", "address_2": "N/A", "postal_code": "08807", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-043-2013", "product_description": "AcneFree 24 Hour Severe Acne Clearing System containing 1-count 4 fl oz (118 mL) bottle Antibacterial Cleansing Wash (benzoyl peroxide 2.5% w/v) AFSV-0101-00, 1-count 4 fl oz (118 mL) bottle Corrective Toner AFSV-0201-01, 1-count 2 fl oz (59 mL) bottle Maximum Strength Repair Lotion (benzoyl peroxide 10% w/v) AFCS-0303-00, and 1-count 1 oz (28 g) bottle AFSV-0305-03, Retinol Renewal Complex per carton, Dist. by: University Medical Pharmaceuticals Corp., Irvine, CA  92618, UPC 7 88521 12900 3.", "product_quantity": "477,107 cartons", "reason_for_recall": "Subpotent (Single Ingredient) Drug: This product was found to be subpotent for the benzoyl peroxide active ingredient.  Additionally, this product is mislabeled because the label either omits or erroneously added inactive ingredients to the label.", "recall_initiation_date": "20121015", "center_classification_date": "20121106", "termination_date": "20130325", "report_date": "20121114", "code_info": "All lots with expiration dates between 10/10/12 through 10/10/14 of UPC 7 88521 12900 3"}, {"status": "Terminated", "city": "Marietta", "state": "GA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA205327"], "brand_name": ["METHYLPHENIDATE HYDROCHLORIDE"], "generic_name": ["METHYLPHENIDATE HYDROCHLORIDE"], "manufacturer_name": ["Trigen Laboratories, LLC"], "product_ndc": ["13811-706", "13811-709", "13811-707", "13811-708", "13811-710"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METHYLPHENIDATE HYDROCHLORIDE"], "rxcui": ["1091155", "1091170", "1091185", "1091210", "1995461"], "spl_id": ["54f7316b-8a84-4145-aecf-f380afbf261b"], "spl_set_id": ["c45dc1de-adfa-4b3c-a7dc-cffbc8eac74f"], "package_ndc": ["13811-709-10", "13811-706-10", "13811-707-10", "13811-708-10", "13811-710-10", "13811-710-30"], "is_original_packager": [true], "upc": ["0313811706109", "0313811709100", "0313811708103", "0313811707106"], "unii": ["4B3SC438HI"]}, "product_type": "Drugs", "event_id": "79365", "recalling_firm": "Osmotica Pharmaceutical Corp", "address_1": "895 Sawyer Rd", "address_2": "N/A", "postal_code": "30062-2257", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0581-2018", "product_description": "Methylphenidate Hydrochloride Extended-release Tablets, USP, 36 mg, 100-count bottle, Rx only, Trigen Laboratories, LLC Bridgewater, NJ 08807. NDC 13811-708-10", "product_quantity": "19,664 100-bottles", "reason_for_recall": "Subpotent Drug:100-count product bottle labeled as Methylphenidate HCL ER Tablets 36 mg found to contain 1 27 mg Methylphenidate HCL ER Tablet.", "recall_initiation_date": "20180228", "center_classification_date": "20180306", "termination_date": "20190501", "report_date": "20180314", "code_info": "Lots: 170231B, 170232A, 170233A, 170234A"}, {"status": "Ongoing", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA075682"], "brand_name": ["IBU"], "generic_name": ["IBUPROFEN"], "manufacturer_name": ["Dr. Reddy's Laboratories Limited"], "product_ndc": ["55111-682", "55111-683", "55111-684"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["IBUPROFEN"], "rxcui": ["197805", "197806", "197807", "206905", "206913", "206917"], "spl_id": ["a7977972-4353-9ca0-d419-e37039010e7d"], "spl_set_id": ["24731405-219c-79b4-ecf0-7d5fbfda94ba"], "package_ndc": ["55111-682-09", "55111-682-01", "55111-682-05", "55111-683-30", "55111-683-50", "55111-683-09", "55111-683-01", "55111-683-05", "55111-684-30", "55111-684-50", "55111-684-60", "55111-684-09", "55111-684-01", "55111-684-05"], "is_original_packager": [true], "nui": ["N0000000160", "M0001335", "N0000175722"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "unii": ["WK2XYI10QM"]}, "product_type": "Drugs", "event_id": "95098", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0645-2024", "product_description": "IBU Ibuprofen Tablets, USP, 600 mg, Rx Only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540, Made in India, a)NDC 55111-683-01 - 100 Tablets per bottle, b)NDC 5511-683-05 - 500 Tablets per bottle.", "product_quantity": "31,802 bottles", "reason_for_recall": "Failed impurities/degradation specifications: results for unknown impurity, were 0.13% and 0.11% respectively, exceeding the 0.10% specification limit.", "recall_initiation_date": "20240806", "center_classification_date": "20240826", "report_date": "20240904", "code_info": "a)NDC 55111-683-01  Lots C2207527, Exp 5/31/2026; C2210864, Exp 9/30/2026; C2213018, Exp 11/30/2026.  b)NDC 5511-683-05  Lots C2207528, Exp 5/31/2026; C2210860, Exp 9/30/2026; C2213016, C2213017, Exp 11/30/2026; C2301852, C2302056, C2302057, Exp 1/31/2027.", "more_code_info": ""}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0134-2015", "product_description": "Sodium tetradecyl sulfate 2% (PF) injectable packaged in an amber glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "6.3 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 08112014@50, Exp 9/10/2014", "more_code_info": ""}, {"status": "Terminated", "city": "San Francisco", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73662", "recalling_firm": "Reliable Rexall-A Compounding Pharmacy", "address_1": "801 Irving St", "address_2": "N/A", "postal_code": "94122-2310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S. Including: CA, HI, NM", "recall_number": "D-1067-2016", "product_description": "All 4-aminopyridine Products, Rx Only, Compounded by RELIABLE DRUG/RELIABLE COMPOUNDING PHARMACY, 801 Irving St., SAN FRANCISCO, CA 94122.", "product_quantity": "N/A", "reason_for_recall": "Lack of Processing Controls", "recall_initiation_date": "20160325", "center_classification_date": "20160706", "termination_date": "20170410", "report_date": "20160713", "code_info": "All lots compounded between 03/24/2015 and 03/24/2016 and within expiry."}, {"country": "United States", "city": "Orlando", "address_1": "6700 Conroy Windermere Rd", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes", "address_2": "Suite 140", "product_quantity": "6", "code_info": "0.75% Lot L5611 Exp 11/30/13 //  1% Lot b3001 Exp 6/19/13, B5014 Exp 8/14/13, and A5431 Exp 6/4/13 //  3% Lot A5808 Exp 12/31/13 //  10% Lot C5328 Exp 9/3/13", "center_classification_date": "20130711", "distribution_pattern": "Nationwide and PR", "state": "FL", "product_description": "Polidocanol (0.75%, 1%, 3%, and 10%) Injection, compounded by Olympia Pharmacy, Orlando, FL", "report_date": "20130717", "classification": "Class II", "openfda": {}, "recalling_firm": "Lowlite Investments, Inc. D/B/A Olympia Pharmacy", "recall_number": "D-773-2013", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "65360", "recall_initiation_date": "20130529", "postal_code": "32835-3500", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91788", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0858-2023", "product_description": "Calcitriol Injection 2 mcg/mL, 1 mL ampules Rx Only, Distributed by: Akorn Operating Company, LLC., Gurnee, IL 60031.  ALL NDCs", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Firm went out of business and could no longer continue stability studies.", "recall_initiation_date": "20230426", "center_classification_date": "20230601", "report_date": "20230607", "code_info": "All Lots"}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-280-2014", "product_description": "TCA 30% 30ml vial, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "1 units", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"status": "Terminated", "city": "Albuquerque", "state": "NM", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86123", "recalling_firm": "Calvin Scott & Company, Inc.", "address_1": "209 Eubank Blvd Ne", "address_2": "N/A", "postal_code": "87123-2745", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1529-2020", "product_description": "Phentermine HCL Blue/White Capsules, 37.5 mg, 28-count bags,  Rx only, Distributed by: Calvin Scott & Co., Inc. Albuquerque, NM 87123, MFG: KVK-Tech., Inc Newtown, PA 18940; NDC 10702-0029-10", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.", "recall_initiation_date": "20200727", "center_classification_date": "20200820", "termination_date": "20240411", "report_date": "20200826", "code_info": "Lot #:19219; Exp. Date: 08/20"}, {"status": "Ongoing", "city": "Ledgewood", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94553", "recalling_firm": "Imprimis NJOF, LLC", "address_1": "1705 Route 46 Ste 6B", "address_2": "", "postal_code": "07852-9720", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0519-2024", "product_description": "Epinephrine-Lidocaine HCl 0.25 mg/mL and 7.5 mg/mL Preservative-Free 1mL Single-Use vial for Intraocular Injection, Imprimis NJOF, LLC. 1705 Route 46 West, unit 6B, Ledgewood, NJ 07852, NDC 71384-640-01", "product_quantity": "74,440 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20240514", "center_classification_date": "20240530", "report_date": "20240605", "code_info": "Lot #: 23JUL025, Exp. Date 7/17/2024; 23SEP012, Exp. Date 7/11/2024; 23OCT015, Exp. Date 7/20/2024; 23OCT020, Exp. Date 7/25/2024; 23OCT026, Exp. Date 8/22/2024; 23NOV030, Exp. Date 8/29/2024, 23DEC026, Exp. Date 9/29/2024; 24JAN011, Exp. Date 7/21/2024;  24FEB033, Exp. Date 8/24/2024; 24JAN050, Exp. Date 8/30/2024", "more_code_info": ""}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "120 pellets", "code_info": "All lots distributed between November 2014 and May 2015;  11262014@20, 5/25/2015; 01152015@27, 7/14/2015; 02232015@21, 8/22/2015; 02242015@23, 8/23/2015; 05052015@68, 11/1/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Estradiol 15 mg, Sterile Pellet, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1467-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Hawthorne", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209207"], "brand_name": ["IBUPROFEN"], "generic_name": ["IBUPROFEN"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["51672-2130"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["IBUPROFEN"], "rxcui": ["197803"], "spl_id": ["39623a94-8b73-17c6-e063-6294a90a4c31"], "spl_set_id": ["f4dad3d6-1366-4bdf-99eb-370ab74a6b9e"], "package_ndc": ["51672-2130-8", "51672-2130-1"], "is_original_packager": [true], "nui": ["N0000000160", "M0001335", "N0000175722"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "unii": ["WK2XYI10QM"]}, "product_type": "Drugs", "event_id": "83887", "recalling_firm": "Taro Pharmaceuticals U.S.A., Inc.", "address_1": "3 Skyline Dr", "address_2": "", "postal_code": "10532-2174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0300-2020", "product_description": "Children's Ibuprofen Oral Suspension USP, 100 mg per 5 mL, Berry Flavor, Dye-Free, Alcohol Free, 4 fl. oz. (120 mL), Distributed by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, NDC 51672-2130-8", "product_quantity": "182,986 bottles", "reason_for_recall": "Presence of Foreign Substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.", "recall_initiation_date": "20190927", "center_classification_date": "20191105", "termination_date": "20230831", "report_date": "20191106", "code_info": "Lot #: E875131667, E875231667, Exp 4/20; J871033189, J871133189, Exp 9/20; A972934375, A973034375, Exp 12/20", "more_code_info": ""}, {"status": "Terminated", "city": "South Richmond Hill", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85992", "recalling_firm": "MasterPharm LLC", "address_1": "11502 Liberty Ave Fl 2", "address_2": "N/A", "postal_code": "11419-1902", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-1438-2020", "product_description": "Tadalafil 26 mg Capsule, 90 capsules per bottle, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419, (866) 630-5600", "product_quantity": "900 capsules", "reason_for_recall": "Lack of Processing Controls (lack of assurance of conformity to specifications).", "recall_initiation_date": "20200702", "center_classification_date": "20200729", "termination_date": "20240223", "report_date": "20200805", "code_info": "01-27-2020:91@23, BUD 7/25/2020  02-26-2020:57@16, BUD 8/24/2020"}, {"status": "Terminated", "city": "Smyrna", "state": "TN", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["M007"], "brand_name": ["CITROMA"], "generic_name": ["MAGESIUM CITRATE"], "manufacturer_name": ["TOPCO ASSOC, LLC"], "product_ndc": ["36800-164"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["MAGNESIUM CITRATE"], "spl_id": ["31e0e200-bc04-43fc-e063-6294a90af4f5"], "spl_set_id": ["d3cc7cb6-098e-413c-b1ad-7ebf5fa35269"], "package_ndc": ["36800-164-38"], "is_original_packager": [true], "unii": ["RHO26O1T9V"], "upc": ["036800455306"]}, "product_type": "Drugs", "event_id": "90599", "recalling_firm": "Vi-Jon, LLC", "address_1": "1 Swan Dr", "address_2": "", "postal_code": "37167-2099", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the USA as well as Canada and Panama.", "recall_number": "D-1508-2022", "product_description": "Topcare health, Magnesium Citrate, SALINE LAXATIVE, Oral Solution, (1.745 g/fl oz), Cherry Flavor, 10 FL OZ (296 mL),  Distributed By Topco Associates LLC Elk Grove Village, IL 60007; NDC 36800-164-38 UPC 0 36800 45530 6", "product_quantity": "18,588 bottles", "reason_for_recall": "Microbial contamination of non-sterile products.", "recall_initiation_date": "20220715", "center_classification_date": "20220909", "termination_date": "20240509", "report_date": "20220921", "code_info": "Lot # 0546394, EXP 9/29/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "74720", "recalling_firm": "Hospira Inc.", "address_1": "275 N Field Dr", "address_2": "N/A", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US and Puerto Rico", "recall_number": "D-0169-2017", "product_description": "5% Lidocaine HCL and 7.5% Dextrose Injection, USP, 2 mL Single-dose ampule, 5 count box, Rx Only, For Spinal Anesthesia Only, Manufactured by Hospira, Inc., Lake Forest, IL 60045, NDC 0409-4712-01", "product_quantity": "287,200  2 mL ampules", "reason_for_recall": "Failed Stability Specifications: The recalled lots did not meet the specification for color and pH throughout shelf life.", "recall_initiation_date": "20160629", "center_classification_date": "20161206", "termination_date": "20191120", "report_date": "20161214", "code_info": "Lot # 34-547-DK, 34-548-DK, Exp. 10/16,   Lot # 39-372-DK, Exp. 03/17     Lot Number may be followed by numbers from 01 to 99"}, {"country": "United States", "city": "Wichita", "address_1": "8710 E 34th St N", "reason_for_recall": "Labeling: Label Error on Declared Strength: syringes of Neostigmine Methylsulfate 1 mg per mL, 5 mg per 5 mL may be incorrectly labeled as Neostigmine Methylsulfate 1 mg per mL, 3 mg per 3 mL.", "address_2": "", "product_quantity": "390 prefilled syringes", "code_info": "Lot #: C274-000004678, BUD: 09/20/18", "center_classification_date": "20180706", "distribution_pattern": "Nationwide in the USA", "state": "KS", "product_description": "Neostigmine Methylsulfate Injection Solution, 3 mg per 3 mL, 1 mg per mL, 3 mL prefilled syringe, 5 syringes per package, Rx only, Fagron Sterile Services, ICB Laboratories, 8710 E 34th St. N., Wichita, KS  67205, NDC 71266-2003-01.", "report_date": "20180711", "classification": "Class I", "openfda": {}, "recalling_firm": "Fagron Compounding Services LLC dba Fagron Sterile Services", "recall_number": "D-0911-2018", "initial_firm_notification": "", "product_type": "Drugs", "event_id": "80383", "termination_date": "20200831", "more_code_info": "", "recall_initiation_date": "20180629", "postal_code": "67226-2636", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "New Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["BLA761234"], "brand_name": ["OPDUALAG"], "generic_name": ["NIVOLUMAB AND RELATLIMAB-RMBW"], "manufacturer_name": ["E.R. Squibb & Sons, L.L.C."], "product_ndc": ["0003-7125"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["NIVOLUMAB", "RELATLIMAB"], "rxcui": ["2596778", "2596784"], "spl_id": ["1150d07b-4d33-4285-a242-1ecf12ed5a4c"], "spl_set_id": ["b22c9d83-3256-4e17-85f7-f331a504adc6"], "package_ndc": ["0003-7125-11"], "is_original_packager": [true], "nui": ["N0000191260", "N0000191259", "N0000194003", "N0000194002"], "pharm_class_epc": ["Programmed Death Receptor-1 Blocking Antibody [EPC]", "Lymphocyte Activation Gene-3 Blocker [EPC]"], "pharm_class_moa": ["Programmed Death Receptor-1-directed Antibody Interactions [MoA]", "Lymphocyte Activation Gene-3 Antagonists [MoA]"], "unii": ["31YO63LBSN", "AF75XOF6W3"]}, "product_type": "Drugs", "event_id": "97839", "recalling_firm": "Bristol-Myers Squibb Company", "address_1": "1 Squibb Dr", "address_2": "", "postal_code": "08901-1588", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0097-2026", "product_description": "Opdualag (nivolumab and relatlimab-rmbw) injection, 240 mg and 80 mg/20 mL (12mg and 4mg/mL),Single Dose Vial, RX Only, Bristol-Myers Squibb Company, Princeton, NJ 08543, NDC 0003-7125-11", "product_quantity": "12,778 total vials", "reason_for_recall": "Lack of Assurance of Sterility.", "recall_initiation_date": "20251021", "center_classification_date": "20251023", "report_date": "20251029", "code_info": "Lot: 033A23B, Expiry: 4/30/2026", "more_code_info": ""}, {"status": "Terminated", "city": "Saint Paul", "state": "MN", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "89797", "recalling_firm": "Fagron, Inc", "address_1": "2400 Pilot Knob Rd", "address_2": "N/A", "postal_code": "55120-1118", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the USA", "recall_number": "D-0866-2022", "product_description": "Nandrolone Decanoate, USP, 1 kg per plastic container, Rx Only, For Prescription Compounding, Distributed by: Humco, 7400 Alumax Road, Texarkana, TX 75501. NDC 0395-8212-43", "product_quantity": "1 containers", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20220304", "center_classification_date": "20220511", "termination_date": "20240714", "report_date": "20220518", "code_info": "Lot #: 18L12-U02-050019, Exp. Date 10/31/2022"}, {"status": "Terminated", "city": "Vicksburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79748", "recalling_firm": "Kroger Specialty Pharmacy, Inc.", "address_1": "100 Pear Orchard Dr Ste A", "address_2": "N/A", "postal_code": "39180-7153", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "MS, LA, AR, IL, FL", "recall_number": "D-0790-2018", "product_description": "Capecitabine 150 mg Tablet NDC 00378-2511-91 28 days supply", "product_quantity": "Unknown", "reason_for_recall": "Lack of Processing Controls.", "recall_initiation_date": "20180403", "center_classification_date": "20180510", "termination_date": "20200507", "report_date": "20180516", "code_info": "All lots remaining within expiry dispensed 12/01/2017 through 02/12/2018"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "81020", "recalling_firm": "Otsuka Pharmaceutical Development & Commercialization, Inc.", "address_1": "508 Carnegie Ctr", "address_2": "", "postal_code": "08540-6259", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0018-2019", "product_description": "treatNOW ABILIFY (aripiprazole) / ABILIFY MAINTENA 400-mg (aripiprazole) for extended release injectable suspension. Kit contents 2 packs Abilify Tablets 10 mg (14 day supply) plus 1 Abilfy Maintena Vial Kit.Rx only. Distributed and Marketed by: Otsuka America Pharmaceutical, Inc. Rockville, MD 20850 USA Marketed by: Lundbleck, Deerfield, IL 60015 USA Bar Code VialKit-59148-10Tabs-02", "product_quantity": "4738 kits", "reason_for_recall": "Labeling Not Elsewhere Classified: Physician sample kits/cartons of treatNOW Abilify are mislabeled. Product name is misspelled, storage instructions are missing and contents of kits may be incorrectly labeled on the outer packaging of the co-packaged kit.", "recall_initiation_date": "20180917", "center_classification_date": "20181012", "termination_date": "20220309", "report_date": "20181010", "code_info": "Lots: 7F92YUD3H1A/ACS1616B, EXP 31-Jul-2019; F92YUD3H1A/ACS0118C, EXP 30-Jun-2020.", "more_code_info": ""}, {"country": "United States", "city": "Bellmawr", "address_1": "136 Harding Ave", "reason_for_recall": "Labeling: Label Mixup; potentially mislabeled", "address_2": "", "product_quantity": "unknown", "code_info": "Lot # C0260416A; Exp. 03/18", "center_classification_date": "20170822", "distribution_pattern": "Nationwide", "state": "NJ", "product_description": "Amitriptyline HCL Tablets, USP 50 mg,  100 count bottles, Rx Only, Manufactured for: Qualitest Pharmaceuticals Huntsville, AL 35811, Distributed by: Truxton, Inc. Bellmawr, NJ 08031, NDC: 0463-6352-10", "report_date": "20170830", "classification": "Class II", "openfda": {}, "recalling_firm": "C. O. Truxton", "recall_number": "D-1115-2017", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "77082", "termination_date": "20180911", "more_code_info": "", "recall_initiation_date": "20170420", "postal_code": "08031-2412", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076286"], "brand_name": ["TIZANIDINE"], "generic_name": ["TIZANIDINE"], "manufacturer_name": ["American Health Packaging"], "product_ndc": ["68084-645", "68084-775"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["TIZANIDINE HYDROCHLORIDE"], "rxcui": ["313412", "313413"], "spl_id": ["35bfea02-ba73-d8c2-e063-6394a90a5c9f"], "spl_set_id": ["3670f9e3-988d-48e6-9df0-d403d699e08a"], "package_ndc": ["68084-645-11", "68084-645-01", "68084-645-65", "68084-775-95", "68084-775-25"], "original_packager_product_ndc": ["55111-180", "55111-179"], "unii": ["B53E3NMY5C"]}, "product_type": "Drugs", "event_id": "92607", "recalling_firm": "Amerisource Health Services LLC", "address_1": "2550 John Glenn Ave Ste A", "address_2": "N/A", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0892-2023", "product_description": "Tizanidine Tablets, USP, 4 mg, 100 Tablets (10 tablets x 10 unit dose blister packs) per carton, Rx Only, Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC 68084-645-01 (carton), barcode (01) 003 68084 645 11 2.", "product_quantity": "4,971 cartons", "reason_for_recall": "Failed Dissolution Specifications: this repackaged product was recalled by the manufacturer, Dr. Reddy's Laboratories, Inc., due to out of specification results for dissolution.", "recall_initiation_date": "20230623", "center_classification_date": "20230630", "termination_date": "20240906", "report_date": "20230712", "code_info": "Lot 1004835, Exp 7/31/2023"}, {"status": "Completed", "city": "Melville", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA204200"], "brand_name": ["ADRENALIN"], "generic_name": ["EPINEPHRINE", "EPINEPRINE"], "manufacturer_name": ["ENDO USA, Inc.", "Henry Schein, Inc."], "product_ndc": ["42023-159", "42023-168", "0404-9810"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS", "SUBCUTANEOUS"], "substance_name": ["EPINEPHRINE"], "rxcui": ["310132", "1490057", "1660014", "1660016"], "spl_id": ["ed8fb63a-8526-4e61-adb4-4da9d3d4f2a0", "d61797df-009f-4a42-ba7d-64fff2d7a321"], "spl_set_id": ["3b7a4364-668d-4eb2-a20c-04adc35aabe4", "b293ad8e-7055-4a95-a130-9d7d74f19eab"], "package_ndc": ["42023-159-01", "42023-159-25", "42023-168-01", "0404-9810-01"], "is_original_packager": [true], "upc": ["0342023168016"], "nui": ["N0000000209", "N0000000245", "N0000175552", "N0000175555", "N0000175570", "M0003647"], "pharm_class_moa": ["Adrenergic alpha-Agonists [MoA]", "Adrenergic beta-Agonists [MoA]"], "pharm_class_epc": ["alpha-Adrenergic Agonist [EPC]", "beta-Adrenergic Agonist [EPC]", "Catecholamine [EPC]"], "pharm_class_cs": ["Catecholamines [CS]"], "unii": ["YKH834O4BH"], "original_packager_product_ndc": ["42023-159"]}, "product_type": "Drugs", "event_id": "93839", "recalling_firm": "Henry Schein Inc. and Glove Club HSI Gloves Inc.", "address_1": "135 Duryea Rd", "address_2": "N/A", "postal_code": "11747-3834", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-0342-2024", "product_description": "Adrenalin (epinephrine) Injection 1mg/mL, 1mL single dose vial, Rx only, Packaged By: Henry Schein, Inc., 80 Summit View Lane, Bastian, VA 24314, Original NDC 42023-159-25 Repack NDC 0404-9810-01", "product_quantity": "1,099 Single Dose Vials", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date. The expiration date listed on the Repack Pouch Label is incorrect.", "recall_initiation_date": "20240117", "center_classification_date": "20240221", "report_date": "20240228", "code_info": "Original Lot # 64103, exp. date 11/24 Repackaged Lot # 39747, exp. date 01/26"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078251"], "brand_name": ["CARVEDILOL"], "generic_name": ["CARVEDILOL"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-162", "68462-163", "68462-164", "68462-165"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CARVEDILOL"], "rxcui": ["200031", "200032", "200033", "686924"], "spl_id": ["5f5b2d20-cc2a-4e91-b2b9-260e7438ab2c"], "spl_set_id": ["c4a21f67-7812-4634-beba-f8e85c63c5f2"], "package_ndc": ["68462-162-60", "68462-162-01", "68462-162-18", "68462-162-05", "68462-162-10", "68462-163-60", "68462-163-01", "68462-163-18", "68462-163-05", "68462-163-10", "68462-164-60", "68462-164-01", "68462-164-18", "68462-164-05", "68462-164-10", "68462-165-60", "68462-165-01", "68462-165-18", "68462-165-05", "68462-165-10"], "is_original_packager": [true], "upc": ["0368462162019", "0368462163016", "0368462164013", "0368462165010"], "nui": ["N0000000099", "N0000009923", "N0000009924", "N0000175553", "N0000175556"], "pharm_class_moa": ["Adrenergic alpha-Antagonists [MoA]", "Adrenergic beta1-Antagonists [MoA]", "Adrenergic beta2-Antagonists [MoA]"], "pharm_class_epc": ["alpha-Adrenergic Blocker [EPC]", "beta-Adrenergic Blocker [EPC]"], "unii": ["0K47UL67F2"]}, "product_type": "Drugs", "event_id": "97370", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0579-2025", "product_description": "Carvedilol Tablets, USP, 25 mg, 500-count bottle, Rx only, Manufactured by: Glenmark Pharmaceuticals Ltd, Colvale-Bardez, Goa, 403513, India. Manufactured for Glenmark Pharmaceuticals, Inc., USA, Mahwah, NJ 07430. NDC 68462-165-05", "product_quantity": "4,800 bottles", "reason_for_recall": "CGMP Deviations: Presence of a nitrosamine,  N-Nitroso Carvedilol I  Impurity above the current Acceptable Intake Level.", "recall_initiation_date": "20250807", "center_classification_date": "20250812", "report_date": "20250820", "code_info": "Lot#:19243104, Expires: 7/31/2026.", "more_code_info": ""}, {"status": "Terminated", "city": "Daytona Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80750", "recalling_firm": "Product Quest Manufacturing LLC", "address_1": "330 Carswell Ave", "address_2": "N/A", "postal_code": "32117-4416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0046-2019", "product_description": "Premier Value, Sterile Saline Nasal Mist, Saline Nasal Moisturizer (0.9% Sodium Chloride) Solution, 4.25 FL OZ (126 mL) can, Distributed By Chain Drug Consortium, 3301 NW Boca Raton Blvd, Suite 101, Boca Raton, FL 33431, NDC 8 40986 02998 1.", "product_quantity": "10,584 cans", "reason_for_recall": "CGMP Deviations: products manufactured under conditions that could impact its product quality.", "recall_initiation_date": "20180803", "center_classification_date": "20181016", "termination_date": "20210330", "report_date": "20181024", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86990", "recalling_firm": "SCA Pharmaceuticals", "address_1": "755 Rainbow Rd Ste B", "address_2": "", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to hospitals nationwide.", "recall_number": "D-0211-2021", "product_description": "Rocuronium Br 50 mg/5mL (10 mg/mL), a) 5 mL Single Dose Syringe Red Label(barcode 7000485009) Rx Only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT, 06095 and b) 5 mL Single Dose Syringe White Label (barcode 70004085028), Rx Only, SCA Pharmaceuticals, 8821 Knoedl Ct, Little Rock, AR 72205", "product_quantity": "13,096 syringes", "reason_for_recall": "Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit", "recall_initiation_date": "20201217", "center_classification_date": "20210107", "termination_date": "20211102", "report_date": "20210113", "code_info": "a) Lot #    1220023011, BUD 1/12/2021;  1220023027, BUD 1/19/2021;  1220023151, BUD 1/26/2021;  1220023152, BUD 1/26/2021;  1220023194, BUD 1/26/2021;  1220023228, BUD 1/28/2021;  1220023358. BUD 2/3/2021;  1220023396. BUD 2/3/2021;  1220023398, BUD 2/10/2021;  1220023569, BUD 2/9/2021 &  1220023633, BUD 2/11/2021.    b)1220023031, BUD 1/19/2021;  1220023032, BUD  1/24/2021;  1220023161, BUD 1/26/2021 &  1220023224, BUD 1/28/2021.", "more_code_info": ""}, {"status": "Terminated", "city": "Corp Christi", "state": "TX", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "76858", "recalling_firm": "Envy Me", "address_1": "7018 Southhaven Dr", "address_2": "", "postal_code": "78412-4132", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Product sold nationwide through internet sales.  No foreign consignees were reported.", "recall_number": "D-0867-2017", "product_description": "LaBri's Body Health Atomic, 60 capsules", "product_quantity": "unknown", "reason_for_recall": "Marketed without an approved NDA/ANDA: Product contains undeclared Sibutramine.", "recall_initiation_date": "20170328", "center_classification_date": "20170525", "termination_date": "20211103", "report_date": "20170531", "code_info": "All lot codes, manufacturing codes and expiration dates.", "more_code_info": ""}, {"status": "Terminated", "city": "Wilsonville", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69519", "recalling_firm": "Oregon Compounding Centers, Inc. dba Creative Compounds", "address_1": "8560 Sw Salish Ln Ste 100", "address_2": "N/A", "postal_code": "97070-9625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Oregon, Washington", "recall_number": "D-0187-2015", "product_description": "DMPS-preservative free, 50 mg/mL, injectable, 5 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070", "product_quantity": "280 mL", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "recall_initiation_date": "20141006", "center_classification_date": "20141031", "termination_date": "20150630", "report_date": "20141112", "code_info": "Lot #: 20140724@24/5, discard date: 10/22/2014;  Lot #: 20140724@25, discard date: 10/22/2014;  Lot #: 20140826@12, discard date: 11/24/2014."}, {"status": "Ongoing", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA075742"], "brand_name": ["RANITIDINE HYDROCHLORIDE"], "generic_name": ["RANITIDINE HYDROCHLORIDE"], "manufacturer_name": ["Dr. Reddy's Laboratories Limited"], "product_ndc": ["55111-129", "55111-130"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["RANITIDINE HYDROCHLORIDE"], "rxcui": ["198190", "198192"], "spl_id": ["9741e6f4-a2dc-7543-1138-da97eafe11bd"], "spl_set_id": ["7bf94bf7-fa11-70be-9f65-fe26a3db5a63"], "package_ndc": ["55111-129-60", "55111-129-05", "55111-130-30", "55111-130-01"], "is_original_packager": [true], "unii": ["BK76465IHM"]}, "product_type": "Drugs", "event_id": "83908", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to major distributors throughout the United States who may have further distributed the product.", "recall_number": "D-0180-2020", "product_description": "Dr. Reddy's Ranitidine Capsules, USP 300 mg, a.) 30 count bottles (NDC 55111-130-30) b.) 100 count bottles (NDC 55111-130-01)", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Presence of NDMA impurity detected in product.", "recall_initiation_date": "20191001", "center_classification_date": "20191105", "report_date": "20191113", "code_info": "Batch Numbers:  All lots within expiry."}, {"status": "Ongoing", "city": "Greenville", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89397", "recalling_firm": "Mayne Pharma Inc", "address_1": "1240 Sugg Pkwy", "address_2": "N/A", "postal_code": "27834-9006", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0387-2022", "product_description": "Lexette (halobetasol propionate) Topical Foam, 0.05% 50 g canisters, Rx ONLY,  Distributed by: Mayne Pharma Greenville, NC 27834, NDC 51862-604-50", "product_quantity": "17,113 canisters", "reason_for_recall": "CGMP Deviation: Difficulty dispensing/does not dispense or dispensing liquid instead of foam.", "recall_initiation_date": "20220114", "center_classification_date": "20220119", "report_date": "20220126", "code_info": "Lot #: 32451 Exp. 03/2022; 32532 Exp. 04/2022; 32552 Exp. 05/2022; 32701 32733 Exp. 10/2022; 32855 Exp. 02/2023; 32872 Exp. 03/2023."}, {"country": "United States", "city": "Asheville", "address_1": "752 Biltmore Ave", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "address_2": "", "product_quantity": "", "code_info": "All lot numbers within expiry.", "center_classification_date": "20140304", "distribution_pattern": "NC", "state": "NC", "product_description": "Terbutaline/Ipratropium 0.5mg/2.5ml", "report_date": "20140312", "classification": "Class II", "openfda": {}, "recalling_firm": "Natures Pharmacy & Compounding Center", "recall_number": "D-1136-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "66856", "termination_date": "20140424", "more_code_info": "", "recall_initiation_date": "20131101", "postal_code": "28803-2558", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Rockford", "address_1": "1718 Northrock Ct", "reason_for_recall": "CGMP Deviations: Pharmaceuticals were produced and distributed with active ingredients not manufactured according to Good Manufacturing Practices.", "address_2": "", "product_quantity": "a) 11,064 cartons; b) 2,052 cartons; c) 5,567 cartons", "code_info": "Lot #: a) 3039795, 3042896, Exp 04/14; b) 3039793, 3042892, Exp 04/14; c) 2120054, Exp 02/14; 2120090, Exp 05/14", "center_classification_date": "20160823", "distribution_pattern": "Nationwide, Puerto Rico and Guam", "state": "IL", "product_description": "Amlodipine Besylate Tablets, USP, 10 mg*, packaged in a) 100-count (10 x 10) unit dose blisters per carton, NDC 51079-452-20; b) 300-count (10 x 30) unit dose blisters per carton, NDC 51079-452-56; and c) 25-count (25 x 1) Robot-Rx Ready Packages in a carton, NDC 51079-452-19; Rx only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV  26505; Packaged and Distributed By: UDL Laboratories, Inc., Rockford, IL  61103.", "report_date": "20160831", "classification": "Class II", "openfda": {}, "recalling_firm": "Mylan Institutional, Inc. (d.b.a. UDL Laboratories)", "recall_number": "D-1468-2016", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "66393", "termination_date": "20180424", "more_code_info": "", "recall_initiation_date": "20130917", "postal_code": "61103-1201", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090778"], "brand_name": ["DULOXETINE"], "generic_name": ["DULOXETINE HYDROCHLORIDE"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "product_ndc": ["57237-017", "57237-018", "57237-019"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DULOXETINE HYDROCHLORIDE"], "rxcui": ["596926", "596930", "596934"], "spl_id": ["4166006e-ead3-4e01-8b11-07d26ac957ed"], "spl_set_id": ["ea2dc1a6-22d5-4295-9d39-9bf015dc5a89"], "package_ndc": ["57237-017-60", "57237-017-99", "57237-018-30", "57237-018-90", "57237-018-99", "57237-019-30", "57237-019-90", "57237-019-99"], "is_original_packager": [true], "upc": ["0357237018309", "0357237017609", "0357237019306"], "unii": ["9044SC542W"]}, "product_type": "Drugs", "event_id": "95756", "recalling_firm": "Rising Pharma Holding, Inc.", "address_1": "2 Tower Center Blvd Ste 1401", "address_2": "", "postal_code": "08816-1149", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-0106-2025", "product_description": "Duloxetine Delayed-Release Capsules USP, 30 mg, a) 30 count (NDC 57237-018-30), b) 90 count (NDC 57237-018-90) and c) 1000 count (NDC 57237-018-99) bottles, Rx only, Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ", "product_quantity": "122,925 bottles", "reason_for_recall": "CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit", "recall_initiation_date": "20241119", "center_classification_date": "20241205", "report_date": "20241211", "code_info": "a) 30s; DT3023019A, exp. date Jan-25 DT3023050A, exp. date Apr-25;  b) 90s; DT3023022A, exp. date Jan-25;  c) 1000s; DT3022108A, DT3022107A, DT3022106A, DT3022111A, DT3022109A, exp. date Nov-24, DT3023001A, DT3023003A, exp. date Dec-24, DT3023024A, DT3023020B, exp. date Jan-25 DT3023027A, DT3023028A, exp. date Feb-25, DT3023034A, exp. date Mar-25, DT3023049A, exp. date Apr-25, DT3023095A, exp. date Jul-25", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0703-2020", "product_description": "BUP 35MG/FENT 1.5MG/ML in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12112019@17 Exp. 12/20/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Allegan", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84127", "recalling_firm": "Perrigo Company PLC", "address_1": "515 Eastern Ave", "address_2": "", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA", "recall_number": "D-1013-2020", "product_description": "Regular Strength Acid Reducer, Ranitidine tablets, USP 75 mg, 60 tablets per bottle. [NDC: Brand] NDC Health Mart: 62011-0283-2; NDC Major: 0904-6715-52; NDC Meijer: 41250-252-72;  NDC Sunmark: 49348-136-12;", "product_quantity": "", "reason_for_recall": "CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.", "recall_initiation_date": "20191023", "center_classification_date": "20200313", "termination_date": "20201106", "report_date": "20200325", "code_info": "Lots: 8DE1367,   8EE1559,   8FE1451,   8GE1340,   8HE1222,   8KE2831,   8JE1917,   8KE2245 ,  8ME2724,   9AE2831,   9DE2747,   9CE3339,   9EE2636,   9FE2971,   9GE2793,   9GE3220", "more_code_info": ""}, {"status": "Ongoing", "city": "Ta. Kadi, District Mehsana", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["M004"], "brand_name": ["RAPIDOL"], "generic_name": ["BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE"], "manufacturer_name": ["Pharmadel LLC"], "product_ndc": ["55758-440"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["BACITRACIN ZINC", "NEOMYCIN SULFATE", "POLYMYXIN B SULFATE"], "rxcui": ["204602"], "spl_id": ["25a394ea-7ad8-78af-e063-6394a90a1947"], "spl_set_id": ["1ad22205-f8c3-b142-e063-6394a90a0044"], "package_ndc": ["55758-440-02"], "is_original_packager": [true], "unii": ["89Y4M234ES", "057Y626693", "19371312D4"], "upc": ["810096771629"]}, "product_type": "Drugs", "event_id": "96797", "recalling_firm": "KENIL HEALTHCARE PRIVATE LIMITED", "address_1": "Plot 319", "address_2": "Village Acharasan, Ankhol-Vamaj Road", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "DE and NC", "recall_number": "D-0429-2025", "product_description": "Rapidol, Triple Antibiotic First Aid Ointment, Bacitracin Zinc/ Neomycin Sulfate/ Polymyxin B Sulfate, Net Wt 2 oz (56g) Tube, Distributed by: Pharmadel LLC, New Castle, DE, 19720, Made in India, NDC 55758-440-02, UPC 8 10096 77162 9.", "product_quantity": "9,336 Tubes", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250424", "center_classification_date": "20250519", "report_date": "20250528", "code_info": "Lot SP27A, Exp: 09/30/2026"}, {"status": "Terminated", "city": "Port Charlotte", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85404", "recalling_firm": "The Medicine Shoppe Pharmacy", "address_1": "3524b Tamiami Trl", "address_2": "", "postal_code": "33952-8100", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Florida", "recall_number": "D-1215-2020", "product_description": "Bi-Est (8:2)/Progesterone 2/100 mg/mL capsule 90 caps bottle, Rx, The Medicine Shoppe Pharmacy, Port Charlotte, FL", "product_quantity": "1 bottle", "reason_for_recall": "Lack of Processing Control", "recall_initiation_date": "20200406", "center_classification_date": "20200410", "termination_date": "20221213", "report_date": "20200422", "code_info": "Lot: 45239 Discard by: 9/16/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Edison", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68793", "recalling_firm": "Daiichi Sankyo Pharma Development", "address_1": "399 Thornall St", "address_2": "", "postal_code": "08837-2236", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-1501-2014", "product_description": "Azor Tablets (amlodipine and olmesartan medoxomil) 10 mg*/40 mg, 30 count bottles, Rx Only, Manufactured for: Daiichi Sankyo, Inc. Parsippany, NJ 07054  NDC 65597-113-30", "product_quantity": "5 bottles", "reason_for_recall": "Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping", "recall_initiation_date": "20140712", "center_classification_date": "20140731", "termination_date": "20150316", "report_date": "20140806", "code_info": "Lot #213655B Exp - 12/31/2017", "more_code_info": ""}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71033", "recalling_firm": "Akorn, Inc.", "address_1": "1925 W. Field Court, Suite 300", "address_2": "N/A", "postal_code": "60045", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide including Puerto Rico", "recall_number": "D-1129-2015", "product_description": "Hydroxyzine Hydrochloride, oral solution, 10 mg per 5 mL, 16 fl oz (473 ml) bottle, Rx only, Manufactured for KVK-Tech, Inc., Newtown, PA by  Hi-Tech Pharmacal Co., Inc., Amityville, NY, NDC 10702-0052-16", "product_quantity": "424,174 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20150407", "center_classification_date": "20150609", "termination_date": "20171129", "report_date": "20150617", "code_info": "Lot# 621637, 621640 Exp 05/2015; 622748, 622751 Exp 08/2015; 623599, 623602 Exp 09/2015; 624132, 624135 Exp 10/2015; 628282, 628285, 628288, 628291 Exp 06/2016; 628850, 628853, 628856, 628859 Exp 07/2016, 629797, 629800, 629803, 629806 Exp 09/2016"}, {"status": "Terminated", "city": "Wilson", "state": "NC", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA074700"], "brand_name": ["BUMETANIDE"], "generic_name": ["BUMETANIDE"], "manufacturer_name": ["Sandoz Inc"], "product_ndc": ["0185-0128", "0185-0129", "0185-0130"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["BUMETANIDE"], "rxcui": ["197417", "197418", "197419"], "spl_id": ["c6f31ac9-10d1-4d92-882e-836de10e1ce6"], "spl_set_id": ["05cb961d-ac33-4bcf-b04e-411e496c43c1"], "package_ndc": ["0185-0128-05", "0185-0128-01", "0185-0129-05", "0185-0129-01", "0185-0130-05", "0185-0130-01"], "is_original_packager": [true], "upc": ["0301850128013", "0301850129010", "0301850130016"], "nui": ["N0000175366", "N0000175590"], "pharm_class_pe": ["Increased Diuresis at Loop of Henle [PE]"], "pharm_class_epc": ["Loop Diuretic [EPC]"], "unii": ["0Y2S3XUQ5H"]}, "product_type": "Drugs", "event_id": "66791", "recalling_firm": "Sandoz Inc", "address_1": "4700 Sandoz Dr", "address_2": "", "postal_code": "27893-8143", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-341-2014", "product_description": "Bumetanide Tablets USP 0.5 mg. Rx Only, a) 100-count Bottle, b) 500-count Bottle, Sandoz Inc., Princeton, NJ 08540, NDC a) 0185-0128-01, b) 0185-0128-05", "product_quantity": "11,496 bottles (100 count) and 62 bottles (500 count)", "reason_for_recall": "Failed Moisture Limit; Out of Specification (OOS) results were obtained for moisture content during stability testing at the 12 month time point, controlled room temperature conditions.", "recall_initiation_date": "20131106", "center_classification_date": "20131206", "termination_date": "20140529", "report_date": "20131218", "code_info": "Lot #: a) CU6131, b) CW1161", "more_code_info": ""}, {"status": "Ongoing", "city": "Athens", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95826", "recalling_firm": "Midlab Incorporated", "address_1": "140 Private Brand Way", "address_2": "", "postal_code": "37303-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0087-2025", "product_description": "MAXIM Assure Antibacterial,  Chloroxylenol 0.1%, Net Contents: One U.S. Gallon (3.78 L), For Industrial and Institutional Use Only, MIDLAB 140 Private Brand Way, Athens, TN 37303", "product_quantity": "", "reason_for_recall": "cGMP Deviations: Out of specification results for micro in hand soap products.", "recall_initiation_date": "20241106", "center_classification_date": "20241202", "report_date": "20241211", "code_info": "Lot 0711241", "more_code_info": ""}, {"country": "United States", "city": "Skillman", "address_1": "199 Grandview Rd", "reason_for_recall": "Defective Container: products showed leakage (bubbles, foaming) of propellant and product from the container valve cup area.", "address_2": "", "product_quantity": "", "code_info": "Lot #: 2617RT1, 2617RT2, 2627RT2,  2637RT1, 2647RT1, 2657RT1, 2627RT2, EXP 05/2019", "center_classification_date": "20180129", "distribution_pattern": "Product was distributed nationwide", "state": "NJ", "product_description": "Neutrogena Elevated 4-Holiday Trays (contains Neutrogena  Deep Clean Purifying Whipped Foam Cleanser)  Case Code: 00070501302866", "report_date": "20180207", "classification": "Class II", "openfda": {}, "recalling_firm": "Johnson & Johnson", "recall_number": "D-0245-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "78610", "termination_date": "20190909", "more_code_info": "", "recall_initiation_date": "20171207", "postal_code": "08558-1311", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "68764", "recalling_firm": "Hospira Inc.", "address_1": "275 N Field Dr", "address_2": "", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0392-2015", "product_description": "LACTATED RINGER'S and 5% DEXTROSE Injection USP, 1000 mL, flexible containers, Rx Only, Hospira, Inc., Lake Forest, IL 600045,  NDC 0409-7929-09", "product_quantity": "142,644 bags", "reason_for_recall": "Non-Sterility: Confirmed customer complaint of particulate matter floating within the solution of the primary container, consistent with mold.", "recall_initiation_date": "20140710", "center_classification_date": "20150217", "termination_date": "20151123", "report_date": "20150225", "code_info": "Lot # 35-118- JT, Exp. 11/15", "more_code_info": ""}, {"status": "Terminated", "city": "Beloeil", "state": "N/A", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84055", "recalling_firm": "8046255 Canada Inc. DBA Viatrexx", "address_1": "1360 Louis-Marchand St", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed to physicians Nationwide throughout the United States and Puerto Rico.", "recall_number": "D-0346-2020", "product_description": "Viatrexx-Neuro, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0460, NDC 73069-375-41.", "product_quantity": "13 vials", "reason_for_recall": "Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.", "recall_initiation_date": "20191015", "center_classification_date": "20191114", "termination_date": "20201210", "report_date": "20191120", "code_info": "Lot Numbers: 19-S00020, Exp. May: 2020"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "49 ml", "code_info": "All lots distributed between November 2014 and May 2015; 01122015@25, 7/11/2015; 02232015@48, 8/22/2015; 03242015, 9/20/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Testosterone USP (10 AQUEOUS) 100 mg/ml Injection, Multi-Dose Vial, Sterile, Room Temperature, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1650-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Ocala", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75289", "recalling_firm": "Wells Pharmacy Network LLC", "address_1": "1210 SW 33rd Ave", "address_2": "N/A", "postal_code": "34474-2853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0362-2017", "product_description": "Indocyanine Green (P.F.), 15 mg Injectable Kit, Compounded by Wells Pharmacy, Ocala, FL", "product_quantity": "131 kits (number of vials per kit vary by prescription)", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160921", "center_classification_date": "20170104", "termination_date": "20210702", "report_date": "20170111", "code_info": "All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry.     Known kit lot code: 08232016@42. Known vial lot code: 08172016@45."}, {"status": "Terminated", "city": "Plainsboro", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA202164"], "brand_name": ["PRAMIPEXOLE DIHYDROCHLORIDE"], "generic_name": ["PRAMIPEXOLE DIHYDROCHLORIDE"], "manufacturer_name": ["Macleods Pharmaceuticals Limited"], "product_ndc": ["33342-031", "33342-032", "33342-033", "33342-034", "33342-035"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PRAMIPEXOLE DIHYDROCHLORIDE"], "spl_id": ["721c81fc-fd21-4d86-ab96-9a329b8e015b"], "spl_set_id": ["b8c94917-73a1-44c2-8fd8-07f45054176b"], "package_ndc": ["33342-031-10", "33342-031-15", "33342-031-06", "33342-031-12", "33342-032-10", "33342-032-15", "33342-032-06", "33342-032-12", "33342-033-10", "33342-033-15", "33342-033-06", "33342-033-12", "33342-034-10", "33342-034-15", "33342-034-06", "33342-034-12", "33342-035-10", "33342-035-15", "33342-035-06", "33342-035-12"], "is_original_packager": [true], "upc": ["0333342031105", "0333342035103", "0333342034106", "0333342033109", "0333342032102"], "unii": ["3D867NP06J"]}, "product_type": "Drugs", "event_id": "73017", "recalling_firm": "Macleods Pharma Usa Inc", "address_1": "666 Plainsboro Rd", "address_2": "Bldg 200  Ste 230", "postal_code": "08536-3030", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide.", "recall_number": "D-0653-2016", "product_description": "Pramipexole Dihydrochloride Tablets 0.125 mg, 90 Ct Bottles, Rx Only. Manufactured for: Macleods Pharma USA, Inc., Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceuticals Ltd., Baddi, Himachal Pradesh, INDIA. NDC: 33342-031-10.", "product_quantity": "N/A", "reason_for_recall": "Presence of Foreign Tablets/Capsules:  Presence of a comingled Carbimazole 5 mg tablet.", "recall_initiation_date": "20151224", "center_classification_date": "20160205", "termination_date": "20200831", "report_date": "20160217", "code_info": "Lot #: BPA512A; Expiry: 06/2017.", "more_code_info": ""}, {"status": "Terminated", "city": "Moses Lake", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71806", "recalling_firm": "JD & SN Inc., dba Moses Lake Professional Pharmacy", "address_1": "1555 Pilgrim St", "address_2": "N/A", "postal_code": "98837-4623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0069-2016", "product_description": "CHORIONIC GONADOTROPIN COMPOUNDED, Injectable Solution, 250 UNITS/0.25ML per syringe, Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA  98837, (509)764-2314", "product_quantity": "40 syringes", "reason_for_recall": "Lack of Assurance of Sterility; all sterile human compounded drugs within expiry", "recall_initiation_date": "20150724", "center_classification_date": "20151027", "termination_date": "20160413", "report_date": "20151104", "code_info": "t04292015@13"}, {"status": "Ongoing", "city": "Anaheim", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91952", "recalling_firm": "Preferred Pharmaceuticals, Inc.", "address_1": "1250 N Lakeview Ave Ste O", "address_2": "", "postal_code": "92807-1801", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0516-2023", "product_description": "Finasteride Tablets, USP, 5 mg, packaged in: a) 30-count bottles (NDC 68788-6976-3); b) 90-count bottles (NDC 68788-6976-9), Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703.", "product_quantity": "a) 135 Bottles, b) 24 Bottles", "reason_for_recall": "cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.", "recall_initiation_date": "20230323", "center_classification_date": "20230406", "report_date": "20230412", "code_info": "a) Lot: A1321V, D0221J, Exp. Date:8/31/2023; Lot: A1322J, Exp. Date: 5/31/2024; Lot: F0221Q, I0121E, I1021R, J1122D, Exp. Date: 10/31/2023; b) Lot: B0422J, Exp. Date: 5/31/2024; Lot: C1721K, Exp. Date: 8/31/2023; Lot: K1022Q, Exp. Date:11/30/2024.", "more_code_info": ""}, {"status": "Terminated", "city": "Ocala", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75289", "recalling_firm": "Wells Pharmacy Network LLC", "address_1": "1210 SW 33rd Ave", "address_2": "N/A", "postal_code": "34474-2853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0423-2017", "product_description": "Testosterone Cypionate in Sesame Oil Injectable, (NY STATE), 200 mg/mL, 10 mL vial, Compounded by Wells Pharmacy, Ocala, FL", "product_quantity": "3 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160921", "center_classification_date": "20170104", "termination_date": "20210702", "report_date": "20170111", "code_info": "All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry.     Known lot code: 04182016@33, 06022016@5"}, {"status": "Terminated", "city": "San Francisco", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73662", "recalling_firm": "Reliable Rexall-A Compounding Pharmacy", "address_1": "801 Irving St", "address_2": "N/A", "postal_code": "94122-2310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S. Including: CA, HI, NM", "recall_number": "D-1108-2016", "product_description": "All squaric acid Products, Rx Only, Compounded by RELIABLE DRUG/RELIABLE COMPOUNDING PHARMACY, 801 Irving St., SAN FRANCISCO, CA 94122.", "product_quantity": "N/A", "reason_for_recall": "Lack of Processing Controls", "recall_initiation_date": "20160325", "center_classification_date": "20160706", "termination_date": "20170410", "report_date": "20160713", "code_info": "All lots compounded between 03/24/2015 and 03/24/2016 and within expiry."}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "3 units", "code_info": "Rx #'s:    0398569    0399778    0398076", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "RANITIDINE 25MG/ML INJECTABLE\t200 ML  \t480 ML  \t800 ML  (3 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1612-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA210464"], "brand_name": ["SEVELAMER CARBONATE FOR ORAL SUSPENSION"], "generic_name": ["SEVELAMER CARBONATE FOR ORAL SUSPENSION"], "manufacturer_name": ["Dr. Reddys Laboratories Inc"], "product_ndc": ["43598-478", "43598-479"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["SEVELAMER CARBONATE"], "rxcui": ["861370", "861375"], "spl_id": ["85e37025-d239-e504-38a0-c2db7ffa0100"], "spl_set_id": ["de172c3d-17eb-3489-35fb-370a0893b663"], "package_ndc": ["43598-478-01", "43598-478-90", "43598-479-01", "43598-479-90"], "is_original_packager": [true], "unii": ["9YCX42I8IU"]}, "product_type": "Drugs", "event_id": "94884", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0625-2024", "product_description": "Sevelamer Carbonate for Oral Suspension 0.8g packets, packaged in 90 packets per container, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540, Made in India NDC 43598-478-90", "product_quantity": "5,136 cartons", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date. Missing lot number and expiration dates on packets", "recall_initiation_date": "20240626", "center_classification_date": "20240802", "report_date": "20240814", "code_info": "Lot #: T2305999, Exp. Date 11/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Melville", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "68683", "recalling_firm": "Fougera Pharmaceuticals  Inc.", "address_1": "60 Baylis Rd", "address_2": "N/A", "postal_code": "11747-3838", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1440-2014", "product_description": "Triamcinolone Acetonide Lotion USP, 0.1%, 60 mL Bottle, Rx Only, For Dermatologic Use Only, Not for Ophthalmic Use, E. Fougera & Co, A Division of Fougera Pharmaceuticals Inc., Melville, New York, 11747, NDC 0168-0337-60.", "product_quantity": "111,388 Bottles", "reason_for_recall": "Failed PH Specifications: It has been determined that the pH of the lots recalled, may not meet specification at expiry.", "recall_initiation_date": "20140703", "center_classification_date": "20140717", "termination_date": "20151207", "report_date": "20140723", "code_info": "Lot(s): 497R, 498R, Exp 01/2015; 635R, 636R, Exp 03/2015;  850R, Exp 04/2015; 073S, Exp 05/2015; 074S, Exp 06/2015."}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0801-2019", "product_description": "Dr. King's SafeCare Rx Expressed Sexual Issues, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955125020, NDC 57955-1257-2", "product_quantity": "10 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lot: 051216M Exp. 05/19"}, {"status": "Terminated", "city": "Noblesville", "state": "IN", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "73297", "recalling_firm": "Pharmakon Pharmaceuticals", "address_1": "14450 Getz Rd", "address_2": "N/A", "postal_code": "46060-3303", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "IN and IL", "recall_number": "D-0871-2016", "product_description": "Morphine Sulfate 0.5 mg/mL, Preservative Free in 0.9% Sodium Chloride,  Rx, total volume 1 mL, This is a compounded drug, CII, IV Use, syringe, Pharmakon Pharmaceuticals, NDC 45183-0322-78.", "product_quantity": "75 Syringes", "reason_for_recall": "Super-Potent Drug: Out of specification for potency results (high) were obtained for one lot of morphine sulfate Inj.", "recall_initiation_date": "20160211", "center_classification_date": "20160525", "termination_date": "20170516", "report_date": "20160601", "code_info": "Lot #: E52418EV11C, Exp 03/19/2016"}, {"country": "United States", "city": "Berkeley", "address_1": "2320 Woolsey St", "reason_for_recall": "Lack of Assurance of Sterility: Firm is recalling all unexpired lots of sterile compounded products after FDA inspection found concerns of lack of sterility assurance.", "address_2": "", "product_quantity": "40 ml", "code_info": "All lots", "center_classification_date": "20160217", "distribution_pattern": "CA", "state": "CA", "product_description": "papaverine phentolamine prostaglandin; 30/2 mg/20 mcg/mL;   5 mL and 10 mL unit sizes, refrigerate, This Rx is Compounded, Abbott's Compounding Pharmacy, Berkeley, CA 94705", "report_date": "20160224", "classification": "Class II", "openfda": {}, "recalling_firm": "Abbott's Compounding Pharmacy, Inc.", "recall_number": "D-0707-2016", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "73090", "termination_date": "20170406", "more_code_info": "", "recall_initiation_date": "20160115", "postal_code": "94705-1973", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Bellmawr", "address_1": "136 Harding Ave", "reason_for_recall": "Labeling: Label Mixup; potentially mislabeled", "address_2": "", "product_quantity": "unknown", "code_info": "Lot # 71416A; Exp. 05/20  Lot # 70881A; Exp. 07/17  Lot # H15A68; Exp. 01/18  Lot # 70980A; Exp. 02/18", "center_classification_date": "20170822", "distribution_pattern": "Nationwide", "state": "NJ", "product_description": "Phenobarbital Tablets USP, 60 mg, 1000 count bottles, Rx Only, Manufactured by West-ward Pharmaceutical Corp. Eatontown, NJ 07724, Distributed by Truxton, Inc., Bellmawr, NJ 08031, NDC 0463-6151-10", "report_date": "20170830", "classification": "Class II", "openfda": {}, "recalling_firm": "C. O. Truxton", "recall_number": "D-1113-2017", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "77082", "termination_date": "20180911", "more_code_info": "", "recall_initiation_date": "20170420", "postal_code": "08031-2412", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "510 pellets", "code_info": "All lots distributed between November 2014 and May 2015;  12122014@8, 6/10/2015; 12042014@47, 6/2/2015; 01122015@54, 7/11/2015; 04142015@82, 10/11/2015; 01072015@32, 7/6/2015; 01192015@17, 7/18/2015; 02042015@43, 8/3/2015; 02232015@35, 8/22/2015; 02272015@30, 8/26/2015; 02272015@19, 8/26/2015; 03162015@55, 9/12/2015; 03192015@23, 9/15/2015; 03192015@33, 9/15/2015; 04012015@55, 9/28/2015; 04072015@42, 10/4/2015, 04072015@6, 10/4/2015; 04102015@46, 10/7/2015; 04162015@56, 10/13/2015; 04282015@7, 10/25/2015, 04272015@59, 10/24/2015; 04302015@59, 10/27/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Testosterone 200 mg, Sterile Pellet, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1745-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA040796"], "brand_name": ["FOLIC ACID"], "generic_name": ["FOLIC ACID"], "manufacturer_name": ["Leading Pharma, LLC"], "product_ndc": ["69315-127"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["FOLIC ACID"], "rxcui": ["310410"], "spl_id": ["92322e52-3179-4738-8c8a-14fef62311d4"], "spl_set_id": ["1ba8c407-9613-4319-ac40-0a429cb0f3f4"], "package_ndc": ["69315-127-01", "69315-127-10"], "is_original_packager": [true], "unii": ["935E97BOY8"]}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0183-2024", "product_description": "FOLIC ACID TABLETS, USP, 1MG, 100 Tablets per bottle, Rx Only, Manufactured by: Leading Pharma, LLC, Fairfield, NJ 07004.  NDC: 69315-127-10", "product_quantity": "1 unit", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch H08221", "more_code_info": ""}, {"status": "Terminated", "city": "Brooklyn", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83136", "recalling_firm": "Infusion Options, Inc.", "address_1": "5924 13th Ave", "address_2": "N/A", "postal_code": "11219-4934", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NY only", "recall_number": "D-1756-2019", "product_description": "CARBOPLATIN 174 MG / 250ml NS IVPB; CARBOPLATIN 240 MG / 250 ML NS IVPB; CARBOPLATIN 750 MG / 250 ML NACL 0.9% IVPB; CARBOPLATIN 895 MG / 250 ML NACL 0.9% IVPB; CARBOPLATIN 235 MG / 250ml NS IVPB  CARBOPLATIN 716 MG / 250 ML D5W IVPB; CARBOPLATIN 400 MG / 500 ML NS IVPB; CARBOPLATIN 500 MG / 100 ML NACL 0.9% IVPB; CARBOPLATIN 575 MG / 500 ML NS IVPB; CARBOPLATIN 307 MG / 100 ML NACL 0.9% IVPB; CARBOPLATIN 766 MG / 500 ML NS IVPB; CARBOPLATIN 684 / 250 ML NACL 0.9% IVPB; CARBOPLATIN 260 MG / 100 ML D5W IVPB  CARBOPLATIN 360 MG /100 ML NACL 0.9% IVPB; CARBOPLATIN 274 MG / 250 ML D5W IVPB; CARBOPLATIN 240 MG / 100 ML D5W IVPB; CARBOPLATIN 750 MG / 250 ML NS IVPB; CARBOPLATIN 260 MG / 250 ML NS IVPB; CARBOPLATIN 460 MG / 250 ML NS IVPB; CARBOPLATIN 175 MG / 250 ML NS IVPB; CARBOPLATIN 229.4 MG / 500 ML NS IVPB  CARBOPLATIN 780 MG / 100 ML NACL 0.9% IVPB; CARBOPLATIN 140 MG / 250 ML NS IVPB; CARBOPLATIN 408 MG / 500 ML NS IVPB  CARBOPLATIN 847 MG / 250 ML D5W IVPB; CARBOPLATIN 560 MG / 250 ML D5W IVPB; CARBOPLATIN 180 MG / 250 ML NS IVPB; CARBOPLATIN 200 MG / 250 ML D5W IVPB; CARBOPLATIN 238 MG / 500 ML NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190612", "center_classification_date": "20190815", "termination_date": "20250321", "report_date": "20190821", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Berkeley Springs", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88528", "recalling_firm": "Washington Homeopathic Products, Inc.", "address_1": "260 J R Hawvermale Way", "address_2": "N/A", "postal_code": "25411-6957", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0893-2021", "product_description": "Aconitum Napellus Fear* Sucrose/Lactose Pills HPUS: 8X, 9X, 12X,30X, packaged in 1 oz containers, Aconitum Napellus Fear* Sucrose/Lactose Pills HPUS: 6X, 10X, 15X, 24X, 30X, packaged in 2 dr containers, Aconitum Napellus Fear* Sucrose/Lactose Pills HPUS: 6X, 30X, packaged in 2 oz containers, Aconitum Napellus Fear* Sucrose/Lactose Pills HPUS: 6X, 7X, 8X, 10X, 12X, 15X, 16X, 18X, 30X, packaged in 4 dram containers, WHP Homeopathic Medicine, Washington Homeopathic Products 260 JR Hawvermale Way, Berkeley Springs, WV 25411.", "product_quantity": "562 bottles", "reason_for_recall": "Out-of-specification test results obtained for identification testing based on HPTLC analysis.", "recall_initiation_date": "20210820", "center_classification_date": "20210929", "termination_date": "20220621", "report_date": "20211006", "code_info": "Lot # 26198"}, {"status": "Terminated", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA202800"], "brand_name": ["ACETAMINOPHEN AND CODEINE PHOSPHATE"], "generic_name": ["ACETAMINOPHEN AND CODEINE PHOSPHATE"], "manufacturer_name": ["Aurolife Pharma, LLC"], "product_ndc": ["13107-058", "13107-059", "13107-060"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ACETAMINOPHEN", "CODEINE PHOSPHATE"], "rxcui": ["993770", "993781", "993890"], "spl_id": ["4c82ae3f-5e61-4b95-821f-1e9a1775682e"], "spl_set_id": ["02386806-02d4-47e3-9c8b-7810146ee795"], "package_ndc": ["13107-058-30", "13107-058-01", "13107-058-05", "13107-058-99", "13107-059-30", "13107-059-01", "13107-059-05", "13107-059-99", "13107-060-30", "13107-060-01", "13107-060-05", "13107-060-99"], "is_original_packager": [true], "unii": ["362O9ITL9D", "GSL05Y1MN6"]}, "product_type": "Drugs", "event_id": "85183", "recalling_firm": "Aurobindo Pharma USA Inc.", "address_1": "279 Princeton Hightstown Rd", "address_2": "", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1230-2020", "product_description": "Acetaminophen and Codeine Phosphate Tablets, USP, 300 mg/30 mg, 100-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., Dayton, NJ 08810, NDC 13107-059-99", "product_quantity": "4332 units", "reason_for_recall": "CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed", "recall_initiation_date": "20200318", "center_classification_date": "20200413", "termination_date": "20240325", "report_date": "20200422", "code_info": "Lot #: 059180023A, 059180024A and 059180025A, Exp. Date 05/2021", "more_code_info": ""}, {"status": "Completed", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90204", "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy", "address_1": "6700 Conroy Rd Ste 155", "address_2": "", "postal_code": "32835-3515", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in th USA, Puerto Rico and US Virgin Islands", "recall_number": "D-0947-2022", "product_description": "QM-2 Papaverine 30 mg/mL Phentolamine 3 mg/mL Alprostadil 60 mcg/mL Atropine 0.2 mg/mL Multi-Dose 10 mL Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155 Orlando, FL 32835. NDC 73198-0018-10.", "product_quantity": "619 vials", "reason_for_recall": "Lack of assurance of sterility.", "recall_initiation_date": "20220509", "center_classification_date": "20220525", "report_date": "20220601", "code_info": "Lot: K24D15 BUD: 11/15/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["BLA021663"], "brand_name": ["MENOPUR"], "generic_name": ["MENOTROPINS"], "manufacturer_name": ["Ferring Pharmaceuticals Inc."], "product_ndc": ["55566-7501"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "rxcui": ["314097", "753990", "1807636"], "spl_id": ["71382717-eeb6-443f-a1a4-6b59990f5ef0"], "spl_set_id": ["22c8db95-c3db-1770-8086-31356fbabe35"], "package_ndc": ["55566-7501-1", "55566-7501-2", "55566-7502-0", "55566-7501-3"], "is_original_packager": [true]}, "product_type": "Drugs", "event_id": "87382", "recalling_firm": "Ferring Pharmaceuticals Inc", "address_1": "100 Interpace Pkwy", "address_2": "", "postal_code": "07054-1149", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed nationwide in the USA.", "recall_number": "D-0299-2021", "product_description": "Menopur 75 IU, (menotropins for injection), packaged as a) 5 single dose vials of Menotropins for injection, 5 single dose vials of 0.9% Sodium Chloride Injection, USP 2 mL, NDC 55566-7501-2; b) Professional Sample Kit: 3 single dose vials of Menotropins for injection, 3 single dose vials of 0.9% Sodium Chloride Injection, USP 2 mL, NDC 55566-7501-3; Rx Only, Manufactured for Ferring Pharmaceuticals Inc. Parsippany. NJ 07054. Diluent manufactured for Ferring Pharmaceuticals Inc.", "product_quantity": "1,155,601 cartons/5 vials per carton 12546 physician samples", "reason_for_recall": "Failed pH specifications: Out of Specification pH results for 0.9% Sodium Chloride, USP", "recall_initiation_date": "20210302", "center_classification_date": "20210311", "termination_date": "20220321", "report_date": "20210317", "code_info": "Lots#   a) P12585AC,    Exp. Date 31-Mar-2020  P12677AA,    Exp. Date 31-Mar-2020  P12678AA,    Exp. Date 31-Jul-2020  P12679AA,    Exp. Date 31-Jul-2020  P12680EA,    Exp. Date 31-Jul-2020  P15461AA,    Exp. Date 31-Jul-2020  P15462AA,    Exp. Date 31-Aug-2020  P15463AA,    Exp. Date 31-Aug-2020  P15870AA,    Exp. Date 31-Aug-2020  P15872AA,    Exp. Date 31-Aug-2020  P16099AA,    Exp. Date 31-Aug-2020  P16100AA,    Exp. Date 30-Sep-2020  P16101AC,    Exp. Date 30-Sep-2020  P16248AA,    Exp. Date 30-Sep-2020  P16770AA,    Exp. Date 30-Nov-2020  P16771AA,    Exp. Date 30-Nov-2020  R10623AA,    Exp. Date 31-Jan-2021  R10624AA,    Exp. Date 31-Jan-2021  R10980AA,    Exp. Date 31-Jan-2021  R11085AA,    Exp. Date 31-Jan-2021  R11086AA,    Exp. Date 31-Jan-2021  R11088AA,    Exp. Date 28-Feb-2021  R11343AA,    Exp. Date 28-Feb-2021  R11416AA,    Exp. Date 28-Feb-2021  R11417AA,    Exp. Date 28-Feb-2021  R11418AA,    Exp. Date 28-Feb-2021  R11419AA,    Exp. Date 28-Feb-2021  R12100AA,    Exp. Date 28-Feb-2021  R12101AA,    Exp. Date 28-Feb-2021  R12102AA,    Exp. Date 31-Mar-2021  R12263CA,    Exp. Date 31-Mar-2021  R12264AA,    Exp. Date 31-Mar-2021  R12598AA,    Exp. Date 31-Mar-2021  R12599AA,    Exp. Date 31-Mar-2021  R12858AA,    Exp. Date 30-Apr-2021  R12859AA,    Exp. Date 30-Apr-2021  R12860AA,    Exp. Date 31-Jul-2021  R12861AA,    Exp. Date 31-Jul-2021  R14321AA,    Exp. Date 30-Nov-2021  R14753AA,    Exp. Date 31-Jul-2021  R14865AA,    Exp. Date 31-Jul-2021  R14866AA,    Exp. Date 31-Jul-2021  R15132AA,    Exp. Date 31-Aug-2021  R15133AA,    Exp. Date 31-Aug-2021  R15330AA,    Exp. Date 31-Aug-2021  R15331AA,    Exp. Date 31-Aug-2021  R15332AA,    Exp. Date 31-Aug-2021  R15333AA,    Exp. Date 31-Aug-2021  R15969AA,    Exp. Date 30-Sep-2021  R15970AA,    Exp. Date 30-Sep-2021  R16231AA,    Exp. Date 30-Sep-2021  R16379AA,    Exp. Date 31-Oct-2021  R16403AA,    Exp. Date 31-Oct-2021  R16405AA,    Exp. Date 31-Oct-2021  R16660AA,    Exp. Date 31-Oct-2021  R16696AA,    Exp. Date 30-Nov-2021  R16770AA,    Exp. Date 31-Oct-2021  R17019AA,    Exp. Date 31-Oct-2021  R17020AA,    Exp. Date 30-Nov-2021  R17148AA,    Exp. Date 30-Nov-2021  S11615AA,    Exp. Date28-Feb-2022  S11616AA,    Exp. Date 28-Feb-2022  S11617AA,    Exp. Date 28-Feb-2022  S11618AA,    Exp. Date 28-Feb-2022  S11619AA,    Exp. Date 28-Feb-2022  S11620AA,    Exp. Date 28-Feb-2022  S11621AA,    Exp. Date 28-Feb-2022  S11623AA,    Exp. Date 28-Feb-2022  S12026AA,    Exp. Date 31-Mar-2022  S12413AA,    Exp. Date 31-Mar-2022  S12436AA,    Exp. Date 31-Mar-2022  S12437AA,    Exp. Date 30-Apr-2022  S12438AA,    Exp. Date 31-May-2022  S12439AA,    Exp. Date 31-May-2022    b) Physician Samples  P16101AA,   Exp. Date 30-Sep-2020  R15332AC,   Exp. Date 31-Aug-2021  S11625AA,  Exp. Date 28-Feb-2022", "more_code_info": ""}, {"status": "Terminated", "city": "Boca Raton", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78553", "recalling_firm": "KRS Global Biotechnology, Inc", "address_1": "791 Park of Commerce Blvd Ste 600", "address_2": "N/A", "postal_code": "33487-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA, Bermuda, and New Zealand", "recall_number": "D-0206-2018", "product_description": "7-Ketodehydroepiandrosterone (7-Keto DHEA) 100 mg Capsule, Rx Only, KRS Global Biotechnology, 791 Park of Commerce Blvd, Boca Raton, FL 33487.", "product_quantity": "90 capsules", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.", "recall_initiation_date": "20171116", "center_classification_date": "20180108", "termination_date": "20200511", "report_date": "20180117", "code_info": "Lot: 08012017@35 BUD: 1/28/2018", "more_code_info": ""}, {"status": "Terminated", "city": "Allegan", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M012"], "brand_name": ["NASAL"], "generic_name": ["OXYMETAZOLINE HYDROCHLORIDE"], "manufacturer_name": ["Meijer Distribution Inc"], "product_ndc": ["41250-989"], "product_type": ["HUMAN OTC DRUG"], "route": ["NASAL"], "substance_name": ["OXYMETAZOLINE HYDROCHLORIDE"], "rxcui": ["1000990"], "spl_id": ["0bba7eea-2347-46a8-aa95-9258cb589a1b"], "spl_set_id": ["ec8db98f-4fd1-4644-b76f-ff04f72e87f4"], "package_ndc": ["41250-989-10"], "is_original_packager": [true], "unii": ["K89MJ0S5VY"]}, "product_type": "Drugs", "event_id": "88905", "recalling_firm": "Perrigo Company PLC", "address_1": "515 Eastern Ave", "address_2": "", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0629-2022", "product_description": "Maximum Strength Nasal Spray, Oxymetazoline HCl 0.05% Nasal Decongestant with Menthol, 1 FL Oz (30 mL) per bottle, DIST. BY MEIJER DISTRIBUTION, INC., GRAND RAPIDS, MI 49544. NDC 41250-989-10", "product_quantity": "144 bottles", "reason_for_recall": "CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.", "recall_initiation_date": "20211026", "center_classification_date": "20220223", "termination_date": "20230929", "report_date": "20220302", "code_info": "Batch: 1BK0716, Exp 12/31/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80118", "recalling_firm": "Guardian Pharmacy Services", "address_1": "7920 Elmbrook Dr Ste 108", "address_2": "N/A", "postal_code": "75247-4933", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Texas", "recall_number": "D-1060-2018", "product_description": "Magnesium Sulfate 200 mg/mL, 100ml. Rx. Only. Packaged in 100 mL MDV vials. Compounded Guardian Pharmacy Services, 7920 Elmbrook Dr. Ste. 108C Dallas TX 75247", "product_quantity": "1000 100-ml vials", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20180517", "center_classification_date": "20180808", "termination_date": "20201125", "report_date": "20180815", "code_info": "Lot: 58212:42 Use By: 06/01/2018"}, {"status": "Terminated", "city": "Garden Grove", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "81512", "recalling_firm": "Kadesh International", "address_1": "9618 Garden Grove Blvd Ste 201", "address_2": "", "postal_code": "92844-1565", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Product was distributed via online stores and retail distributors Nationwide in the USA, Uruguay, Canada, China, Dominican Republic, Korea, and Vietnam.", "recall_number": "D-0250-2019", "product_description": "puriton EYE RELIEF DROPS, 0.5 oz (15 ml) bottle, Kadesh Inc., NDC#7079600115, UPC 7 36972 16799 0.", "product_quantity": "18,521 bottles", "reason_for_recall": "Non-Sterility: Product manufactured under non-sterile production conditions.", "recall_initiation_date": "20181105", "center_classification_date": "20181119", "termination_date": "20230124", "report_date": "20181121", "code_info": "All lots, no expiration dates are on the bottles.", "more_code_info": ""}, {"status": "Terminated", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78791", "recalling_firm": "SHISEIDO AMERICA INC.", "address_1": "366 Princeton Hightstown Rd", "address_2": "N/A", "postal_code": "08520-1411", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide.", "recall_number": "D-0217-2018", "product_description": "Shiseido Future Solution LX Luxurious Eye & Lip Collection contains SPF 50+ (octinoxate 4.9%, octocrylebe 3.0%, oxybenzone 1.0% and zinc oxide 15.4%), packaged in 15 mL tubes, Shiseido Americas Corporation Dist. New York, NY 10022", "product_quantity": "N/A", "reason_for_recall": "GMP Deviations: manufacturing of API material did not meet GMP and quality requirements.", "recall_initiation_date": "20171214", "center_classification_date": "20180112", "termination_date": "20210624", "report_date": "20180124", "code_info": "SKU#: 95393"}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91788", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0783-2023", "product_description": "Albuterol Sulfate Syrup, 2mg (base), 16 fl oz (473 mL) per bottle, Rx only, Distributed by: Akorn Operating Company LLC, Gurnee, IL 60031.  ALL NDCs", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Firm went out of business and could no longer continue stability studies.", "recall_initiation_date": "20230426", "center_classification_date": "20230601", "report_date": "20230607", "code_info": "All Lots"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73925", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-0045-2017", "product_description": "glycopyrrolate, 0.2 mg per mL, 0.4 mg per 2 mL, 2 mL Total Volume in a syringe, For IV Use, Rx only, PharMEDium, Product code 2R3329.", "product_quantity": "17462 syringes", "reason_for_recall": "Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.", "recall_initiation_date": "20150717", "center_classification_date": "20161012", "termination_date": "20170623", "report_date": "20161019", "code_info": "Lot Numbers: 15117086M, 15117087M, 15117088M, 15118090M, 15120069M, 15120070M, 15124086M, 15126074M, 15126075M, 15127031M, 15127095M,   15133009M, 15133079M, 15134011M, 15134022M, 15134065M, 15140004M, 15140046M, 15140086M, 15141022M, 15141023M, 15141042M, 15142094M, 15147098M, 15149114M, 15149115M, 151520082M, 151520100M, 151520101M, 151520102M, 15152054M, 151740174M, 151880153M, 151890124M, 151900020M, 151910018M, Exp between 07/15/15-10/12/15"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0888-2019", "product_description": "Dr. King's SafeCare Rx Sporting Edge, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 35795500312, NDC 57955-0031-2", "product_quantity": "142 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 122815C Exp. 12/18; 101716A Exp. 10/19"}, {"status": "Terminated", "city": "Pulaski", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76617", "recalling_firm": "AVKARE Inc.", "address_1": "615 N 1st St", "address_2": "", "postal_code": "38478-2403", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0610-2017", "product_description": "Famciclovir tablets, 500 mg, packaged in 30-count unit dose cartons, Rx only, Manufactured for:  AvKARE, Inc., Pulaski, TN 38478, NDC 50268-307-13", "product_quantity": "116 cartons", "reason_for_recall": "Failed impurities/ degradation specifications: Product was above specification for unknown impurities.", "recall_initiation_date": "20170215", "center_classification_date": "20170322", "termination_date": "20220601", "report_date": "20170329", "code_info": "Lot #15152, Exp. 02/2018", "more_code_info": ""}, {"status": "Terminated", "city": "Punxsutawney", "state": "PA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "73167", "recalling_firm": "Bee Xtreme", "address_1": "506 N Penn St", "address_2": "N/A", "postal_code": "15767-1527", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Unknown", "recall_number": "D-0021-2017", "product_description": "Jenesis Dietary Supplement Capsules, 350 mg, 60 count bottles, Manufactured for Timeless Solutions, 1810 E Sahara Ave #100, Las Vegas, Nevada 89104, distributed by BeeXtreme LLC, Punxsutawney PA", "product_quantity": "13 bottles", "reason_for_recall": "Marketed without an Approved NDA/ANDA; FDA analysis found them to contain sibutramine and phenolphthalein", "recall_initiation_date": "20151223", "center_classification_date": "20161012", "termination_date": "20170130", "report_date": "20161019", "code_info": "All Lots"}, {"status": "Completed", "city": "Aquebogue", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83265", "recalling_firm": "Altaire Pharmaceuticals, Inc.", "address_1": "311 W Ln", "address_2": "PO Box 849", "postal_code": "11931-0849", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0405-2020", "product_description": "CVS Health Fast Acting Lubricant Eye Drops Preservative Free, Item#: 994882, Product Size: 0.6 mL x 24 ct, Distributed by: CVS Pharmacy, Inc. One CVS Drive, Woonsocket, RI 02895", "product_quantity": "58,704 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190702", "center_classification_date": "20191115", "report_date": "20191127", "code_info": "RIN 09/19   RKP 11/19    SAR 01/20   SCG 03/20   SED 5/20   SLC 12/20   TBE 02/21   TBL 02/21"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92898", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1138-2023", "product_description": "dilTIAZem 125mg/125mL (1 mg/mL), added to dextrose 5%,  IV Bag, RX only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Phoenix, AZ 85043, NDC: 72196-6054-1", "product_quantity": "703 bags.", "reason_for_recall": "Lack of Assurance of Sterility:Lack of validation data for sanitization cycles", "recall_initiation_date": "20230817", "center_classification_date": "20230828", "termination_date": "20250327", "report_date": "20230906", "code_info": "Lot# 36-260048, Exp 9/13/2023; 36-262174, Exp 9/15/2023; 36-262523, Exp 9/19/2023.                  ;"}, {"status": "Ongoing", "city": "Nicholasville", "state": "KY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89909", "recalling_firm": "TMC Acquisition LLC dba Tailor Made Compounding", "address_1": "200 Moore Dr", "address_2": "", "postal_code": "40356-8512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA and Puerto Rico", "recall_number": "D-1208-2022", "product_description": "Hydroxocobalamin 25mg/mL, 10mL-vial, Room Temperature, Tailor Made Compounding", "product_quantity": "63 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20220307", "center_classification_date": "20220714", "report_date": "20220720", "code_info": "Batch#: 12222104A2, Exp 3/22/2022; 01032224A2, Exp 4/3/2022; 01282217A2, Exp 4/28/2022; 02192211A1; Exp 5/20/2022.", "more_code_info": ""}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA050441"], "brand_name": ["CLEOCIN PHOSPHATE"], "generic_name": ["CLINDAMYCIN PHOSPHATE"], "manufacturer_name": ["Pharmacia & Upjohn Company LLC"], "product_ndc": ["0009-0728", "0009-0870", "0009-0775", "0009-0902", "0009-3124", "0009-3447", "0009-3381", "0009-3375", "0009-3382", "0009-6582"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["CLINDAMYCIN PHOSPHATE"], "rxcui": ["205964", "309335", "309336", "309339", "685574", "685576", "685578", "706461", "1737244", "1737245", "1737578", "1737579", "1737581", "1737582"], "spl_id": ["cb513686-3220-4de2-8be6-f941273ae842"], "spl_set_id": ["05a75685-0af5-407c-ac57-e380c882b49d"], "package_ndc": ["0009-0870-21", "0009-0870-26", "0009-0775-20", "0009-0775-26", "0009-0902-11", "0009-0902-18", "0009-0728-05", "0009-0728-09", "0009-3124-01", "0009-3124-03", "0009-3447-01", "0009-3447-03", "0009-3381-01", "0009-3381-02", "0009-3375-01", "0009-3375-02", "0009-3382-01", "0009-3382-02", "0009-6582-02", "0009-6582-01"], "is_original_packager": [true], "unii": ["EH6D7113I8"]}, "product_type": "Drugs", "event_id": "82386", "recalling_firm": "Pfizer Inc.", "address_1": "235 E 42nd St", "address_2": "N/A", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA and Guam", "recall_number": "D-1067-2019", "product_description": "Cleocin Phosphate (clindamycin injection), USP, 300 mg/ 2 mL (150 mg/mL), 2 mL-vial, Rx only, Distributed by Pharmacia & Upjohn Co, Division of Pfizer, Inc, New York, NY 10017, NDC 0009-6582-02", "product_quantity": "67 cartons (25 vials per carton)", "reason_for_recall": "Failed Impurities/Degradation Specifications: High out-of-specification (OOS) results were demonstrated for several specified impurities at the 24-month time point", "recall_initiation_date": "20190315", "center_classification_date": "20190329", "termination_date": "20220811", "report_date": "20190410", "code_info": "Lot #: T97469, Exp. 7/2019, W28574, Exp.09/2019"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71104", "recalling_firm": "Wockhardt Usa Inc.", "address_1": "20 Waterview Blvd Ste 3", "address_2": "N/A", "postal_code": "07054-1271", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide including Puerto Rico.", "recall_number": "D-1258-2015", "product_description": "Lisinopril Tablets USP, 10 mg Tablets, Packaged in A) 100 Count Bottles (NDC: 64679-929-01), B) 500 Count Bottles (NDC: 64679-929-05), and C) 1000 Count Bottles (NDC: 64679-929-06), Rx Only. Manufactured by: Wockhardt Limited, Mumbai, India. Distributed by: Wockhardt USA LLC 20 Waterview Blvd. Parsippany, NJ 07054 USA.", "product_quantity": "A) 133,920 Bottles, B) 6705 Bottles, and C) 137,659 Bottles.", "reason_for_recall": "CGMP Deviations: Firm did not adequately investigate customer complaints.", "recall_initiation_date": "20150422", "center_classification_date": "20150717", "termination_date": "20180509", "report_date": "20150729", "code_info": "A) Lot #: DM11197, Expiry: 4/30/2015; Lot #: DM11202, Expiry: 4/30/2015; Lot #: DM11641, Expiry: 6/30/2015; Lot #: DM12237, Expiry: 8/31/2015; Lot #: DM12238, Expiry: 8/31/2015, Lot #: DM12285, Expiry: 8/31/2015; Lot #: DN10176, Expiry: 12/31/2015; Lot #: DN10636, Expiry: 1/31/2016; Lot #: DN10869, Expiry: 2/29/2016.  B) Lot #: DM11646, Expiry: 6/30/2015; Lot #: DM12364, Expiry: 8/31/2015. C) Lot #: DM11136, Expiry: 4/30/2015; Lot #: DM11137, Expiry: 4/30/2015; Lot #: DM11142, Expiry: 4/30/2015; Lot #: DM11150, Expiry: 4/30/2015; Lot #: DM11176, Expiry: 4/30/2015; Lot #: DM11212, Expiry: 4/30/2015; Lot #: DM11213, Expiry: 5/31/2015; Lot #: DM11214, Expiry: 5/31/2015; Lot #: DM11222, Expiry: 5/31/2015; Lot #: DM11223, Expiry: 5/31/2015; Lot #: DM11270, Expiry: 5/31/2015; Lot #: DM11277, Expiry: 5/31/2015; Lot #: DM11278, Expiry: 5/31/2015; Lot #: DM11289, Expiry: 5/31/2015; Lot #: DM11290, Expiry: 5/31/2015; Lot #: DM11291, Expiry: 5/31/2015; Lot #: DM11322, Expiry: 5/31/2015; Lot #: DM11499, Expiry: 5/31/2015; Lot #: DM11538, Expiry: 5/31/2015; Lot #: DM11539, Expiry: 5/31/2015; Lot #: DM11540, Expiry: 5/31/2015, Lot #: DM11541, Expiry: 5/31/2015; Lot #: DM11542, Expiry: 5/31/2015; Lot #: DM11543, Expiry: 5/31/2015; Lot #: DM11601, Expiry: 6/30/2015; Lot #: DM11602, Expiry: 6/30/2015; Lot #: DM11617, Expiry: 6/30/2015; Lot #: DM11623, Expiry: 6/30/2015; Lot #: DM11624, Expiry: 6/30/2015; Lot #: DM11825, Expiry: 6/30/2015; Lot #: DM11826, Expiry: 6/30/2015; Lot #: DM11831, Expiry: 6/30/2015; Lot #: DM11875, Expiry: 6/30/2015; Lot #: DM11876, Expiry: 6/30/2015; Lot #: DM11877, Expiry: 6/30/2015; Lot #: DM11878, Expiry: 6/30/2015: Lot #: DM11883, Expiry: 6/30/2015, Lot #: DM11918, Expiry: 6/30/2015; Lot #: DM11919, Expiry: 6/30/2015; Lot #: DM11922, Expiry: 7/31/2015; Lot #: DM11923, Expiry: 7/31/2015; Lot #: DM11962, Expiry: 7/31/2015; Lot #: DM11963, Expiry: 7/31/2015; Lot #: DM12248, Expiry: 8/31/2015; Lot #: DM12249, Expiry: 8/31/2015; Lot #: DM12263, Expiry: 8/31/2015: Lot #: DM12306, Expiry: 8/31/2015; Lot #: DM12317, Expiry: 8/31/2015; Lot #: DM12349, Expiry: 8/31/2015; Lot #: DM12350, Expiry: 8/31/2015; Lot #: DM12351, Expiry: 8/31/2015; Lot #: DM12388, Expiry: 8/31/2015; Lot #: DM12389, Expiry: 8/31/2015; Lot #: DM13100, Expiry: 9/30/2015; Lot #: DM13052, Expiry: 9/30/2015; Lot #: DM13053, Expiry: 9/31/2015; Lot #: DM13101, Expiry: 9/30/2015; Lot #: DM13354, Expiry: 9/30/2015; Lot #: DN10148, Expiry: 11/30/2015; Lot #: DN10152, Expiry: 11/30/2015; Lot #: DN10154, Expiry: 12/31/2015; Lot #: DN10155, Expiry: 12/31/2015; Lot #: DN10175, Expiry: 12/31/2015; Lot #: DN10180; Expiry: 12/31/2015; Lot #: DN10185, Expiry: 12/31/2015; Lot #: DN10195, Expiry: 12/31/2015; Lot #: DN10204, Expiry: 12/31/2015; Lot #: DN10213, Expiry: 12/31/2015; Lot #: DN10594, Expiry: 1/31/2016; Lot #: DN10595, Expiry: 1/31/2016; Lot #: DN10606, Expiry: 1/31/2016; Lot #: DN10607, Expiry: 1/31/2016; Lot #: DN10630, Expiry: 1/31/2016; Lot #: DN10637, Expiry: 1/31/2016; Lot #: DN10638, Expiry: 1/31/2016; Lot #: DN10767, Expiry: 2/29/2016; Lot #: DN10768, Expiry: 2/29/2016; Lot #: DN10769, Expiry: 9/30/2015; Lot #: DN10777, Expiry: 2/29/2016; Lot #: DN10782, Expiry: 2/29/2016; Lot #: DN10783, Expiry: 1/31/2016; Lot #: DN10784, Expiry: 2/29/2016; Lot #: DN10834, Expiry: 2/29/2016; Lot #: DN10835, Expiry: 2/29/2016."}, {"status": "Terminated", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82782", "recalling_firm": "Heritage Pharmaceuticals, Inc.", "address_1": "1 Tower Center Blvd Ste 1700", "address_2": "N/A", "postal_code": "08816-1145", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-1287-2019", "product_description": "Losartan Potassium Tablets, USP 50 mg 1000 film coated tablets Rx Only  Manufactured by: Vivimed Life Sciences Private Limited, Plot No. 101, 102, 107 & 108  SIDCO Pharmaceutical Complex, Alathur, Kanchipuram - 603 110, Tamilnadu, India.   Manufactured for: Heritage Pharmaceuticals Inc., East Brunswick, NJ 08816. 1-866-901-DRUG (3784)  NDC 23155-645-10", "product_quantity": "3012 bottles", "reason_for_recall": "CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level at the manufacturer", "recall_initiation_date": "20190503", "center_classification_date": "20190521", "termination_date": "20201116", "report_date": "20190529", "code_info": "Lot CLO17007A    Lot CLO17008A       Lot CLO17009A ; Exp 11/2019"}, {"status": "Terminated", "city": "New Paltz", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89464", "recalling_firm": "Ultra Seal Corporation", "address_1": "521 Main St", "address_2": "N/A", "postal_code": "12561-1609", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0465-2022", "product_description": "Cold Tablet Pain Reliever/Fever Reducer/Expectorant/Nasal Decongestant (acetaminophen 325 mg, Guaifenesin 200mg, Phenylephrine HCl 5 mg) 2 tablets per packet, Mfg, for Respond Industries and American First Aid, Mason, OH 45040", "product_quantity": "313,000 packets", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20220124", "center_classification_date": "20220131", "termination_date": "20231016", "report_date": "20220209", "code_info": "Lot #: K9824, Exp. Date 09/2022"}, {"status": "Terminated", "city": "El Paso", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87592", "recalling_firm": "CareFusion 213, LLC", "address_1": "1550 Northwestern Dr", "address_2": "N/A", "postal_code": "79912-8000", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the USA and to Singapore, Chile, Oman, Columbia, United Arab Emirates, South Africa, Kuwait, Democratic Republic of the Congo, Qatar, Bahrain, Hong Kong, Brazil.", "recall_number": "D-0349-2021", "product_description": "ChloraPrep One-Step 2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA) Non-Sterile Solution -Clear, 0.10 fl. oz. (3ml) each, 25 applicators per carton, applicator is sterile if package is intact. CareFusion El Paso, TX 79912, NDC 054365-400-01 Cat. No. 260400", "product_quantity": "40,720,900 cartons", "reason_for_recall": "CGMP Deviations:  Product is being recalled because at labeled storage conditions of 30*C/75% Relative Humidity, there is the potential for growth of Aspergillus penicillioides, a type of fungus, resulting in a breach of the package integrity.", "recall_initiation_date": "20210319", "center_classification_date": "20210426", "termination_date": "20220929", "report_date": "20210505", "code_info": "Lot and Exp Date:  0000192, 12/31/2022;  0007621, 12/31/2022;  0008775, 12/31/2022;  0009111, 12/31/2022;  0011738, 12/31/2022;  0011753, 12/31/2022;  0011754, 12/31/2022;  0011755, 12/31/2022;  0013604, 12/31/2022;  0015498, 12/31/2022;  0015500, 12/31/2022;  0016329, 1/31/2023;  0017929, 12/31/2022;  0021945, 1/31/2023;  0028887, 1/31/2023;  0031093, 1/31/2023;  0034660, 1/31/2023;  0035149, 1/31/2023;  0036460, 1/31/2023;  0037272, 1/31/2023;  0038213, 1/31/2023;  0038217, 1/31/2023;  0041893, 1/31/2023;  0042483, 1/31/2023;  0042501, 1/31/2023;  0043105, 1/31/2023;  0044739, 1/31/2023;  0094838, 2/28/2023;  0098051, 2/28/2023;  0104859, 3/31/2023;  0129330, 4/30/2023;  0133069, 4/30/2023;  0220728, 7/31/2023;  0223036, 7/31/2023;  8078998, 3/31/2021;  8079620, 3/31/2021;  8079621, 3/31/2021;  8082921, 3/31/2021;  8082923, 3/31/2021;  8085804, 3/31/2021;  8088708, 3/31/2021;  8089621, 3/31/2021;  8093619, 3/31/2021;  8093813, 3/31/2021;  8094833, 3/31/2021;  8096706, 3/31/2021;  8097822, 3/31/2021;  8099727, 3/31/2021;  8099783, 3/31/2021;  8100947, 3/31/2021;  8101636, 3/31/2021;  8101719, 3/31/2021;  8102691, 3/31/2021;  8103673, 4/30/2021;  8108795, 4/30/2021;  8109707, 4/30/2021;  8110645, 4/30/2021;  8110674, 4/30/2021;  8114540, 4/30/2021;  8114547, 4/30/2021;  8115574, 4/30/2021;  8116705, 4/30/2021;  8120701, 4/30/2021;  8120985, 4/30/2021;  8122873, 4/30/2021;  8122874, 4/30/2021;  8124914, 4/30/2021;  8127649, 4/30/2021;  8127650, 4/30/2021;  8129680, 4/30/2021;  8129686, 4/30/2021;  8134847, 4/30/2021;  8134850, 4/30/2021;  8136811, 5/31/2021;  8137525, 5/31/2021;  8138867, 5/31/2021;  8141821, 5/31/2021;  8143659, 5/31/2021;  8144768, 5/31/2021;  8144882, 5/31/2021;  8145889, 5/31/2021;  8150625, 5/31/2021;  8151713, 5/31/2021;  8151736, 5/31/2021;  8152581, 5/31/2021;  8156507, 5/31/2021;  8156735, 5/31/2021;  8157866, 5/31/2021;  8157993, 5/31/2021;  8158595, 5/31/2021;  8158633, 5/31/2021;  8159995, 5/31/2021;  8164525, 6/30/2021;  8165696, 6/30/2021;  8167970, 6/30/2021;  8170535, 6/30/2021;  8170538, 6/30/2021;  8171503, 6/30/2021;  8172910, 6/30/2021;  8173655, 6/30/2021;  8176731, 6/30/2021;  8177746, 6/30/2021;  8178576, 6/30/2021;  8178654, 6/30/2021;  8179928, 6/30/2021;  8179974, 6/30/2021;  8180627, 6/30/2021;  8186700, 6/30/2021;  8190916, 6/30/2021;  8190987, 6/30/2021;  8192557, 6/30/2021;  8192881, 6/30/2021;  8197514, 6/30/2021;  8197515, 6/30/2021;  8198763, 7/31/2021;  8199675, 7/31/2021;  8204574, 7/31/2021;  8206898, 7/31/2021;  8211903, 7/31/2021;  8212879, 7/31/2021;  8214989, 7/31/2021;  8214995, 7/31/2021;  8215994, 7/31/2021;  8218645, 7/31/2021;  8219946, 7/31/2021;  8219988, 7/31/2021;  8222798, 7/31/2021;  8225863, 7/31/2021;  8225868, 7/31/2021;  8228632, 8/31/2021;  8229682, 8/31/2021;  8232739, 8/31/2021;  8233569, 8/31/2021;  8235983, 8/31/2021;  8239901, 8/31/2021;  8239902, 8/31/2021;  8240966, 8/31/2021;  8241848, 8/31/2021;  8243756, 8/31/2021;  8247510, 8/31/2021;  8248570, 8/31/2021;  8249934, 8/31/2021;  8257619, 8/31/2021;  8260778, 9/30/2021;  8261945, 9/30/2021;  8261946, 9/30/2021;  8262674, 9/30/2021;  8263865, 9/30/2021;  8265679, 9/30/2021;  8267928, 9/30/2021;  8267929, 9/30/2021;  8268617, 9/30/2021;  8268618, 9/30/2021;  8269913, 9/30/2021;  8271911, 9/30/2021;  8274999, 9/30/2021;  8275615, 9/30/2021;  8275625, 9/30/2021;  8276694, 9/30/2021;  8277635, 9/30/2021;  8277637, 9/30/2021;  8282884, 9/30/2021;  8283738, 9/30/2021;  8284622, 9/30/2021;  8285592, 9/30/2021;  8288852, 9/30/2021;  8290569, 9/30/2021;  8291769, 10/31/2021;  8292703, 10/31/2021;  8292708, 10/31/2021;  8296693, 10/31/2021;  8296695, 10/31/2021;  8299673, 10/31/2021;  8303606, 10/31/2021;  8304839, 10/31/2021;  8306692, 10/31/2021;  8309553, 10/31/2021;  8310641, 10/31/2021;  8311789, 10/31/2021;  8313646, 10/31/2021;  8313687, 10/31/2021;  8319821, 10/31/2021;  8320984, 11/30/2021;  8323514, 11/30/2021;  8323745, 11/30/2021;  8325725, 11/30/2021;  8325749, 11/30/2021;  8331695, 11/30/2021;  8341526, 11/30/2021;  8344689, 11/30/2021;  8345987, 11/30/2021;  8345988, 11/30/2021;  8346840, 11/30/2021;  8347713, 11/30/2021;  8348560, 11/30/2021;  8351524, 12/31/2021;  8351527, 12/31/2021;  8354841, 12/31/2021;  8355555, 12/31/2021;  8355665, 12/31/2021;  9007932, 12/31/2021;  9008954, 12/31/2021;  9008963, 12/31/2021;  9009962, 12/31/2021;  9010973, 12/31/2021;  9014968, 12/31/2021;  9017714, 12/31/2021;  9017716, 12/31/2021;  9021962, 1/31/2022;  9022804, 12/31/2021;  9022808, 12/31/2021;  9023539, 1/31/2022;  9023541, 1/31/2022;  9028693, 1/31/2022;  9030936, 1/31/2022;  9035603, 1/31/2022;  9036759, 1/31/2022;  9036761, 1/31/2022;  9037816, 1/31/2022;  9038527, 1/31/2022;  9039888, 1/31/2022;  9039889, 1/31/2022;  9042932, 1/31/2022;  9043626, 1/31/2022;  9044570, 1/31/2022;  9049788, 2/28/2022;  9049790, 2/28/2022;  9051558, 2/28/2022;  9053553, 2/28/2022;  9053605, 2/28/2022;  9056781, 2/28/2022;  9057597, 2/28/2022;  9057600, 2/28/2022;  9058797, 2/28/2022;  9064561, 2/28/2022;  9067661, 2/28/2022;  9070712, 2/28/2022;  9072853, 2/28/2022;  9073968, 2/28/2022;  9074967, 2/28/2022;  9077861, 2/28/2022;  9079525, 3/31/2022;  9079746, 3/31/2022;  9085737, 3/31/2022;  9093920, 3/31/2022;  9094797, 3/31/2022;  9098940, 3/31/2022;  9099817, 3/31/2022;  9100771, 3/31/2022;  9100776, 3/31/2022;  9106945, 3/31/2022;  9106950, 3/31/2022;  9107765, 4/30/2022;  9107767, 4/30/2022;  9112666, 4/30/2022;  9112668, 4/30/2022;  9113527, 4/30/2022;  9114610, 4/30/2022;  9114611, 4/30/2022;  9116696, 4/30/2022;  9116698, 4/30/2022;  9119832, 4/30/2022;  9120522, 4/30/2022;  9120523, 4/30/2022;  9121774, 4/30/2022;  9122536, 4/30/2022;  9123755, 4/30/2022;  9127963, 4/30/2022;  9127968, 4/30/2022;  9128862, 4/30/2022;  9129660, 4/30/2022;  9130717, 4/30/2022;  9136917, 5/31/2022;  9138989, 5/31/2022;  9140678, 5/31/2022;  9140679, 5/31/2022;  9141792, 5/31/2022;  9143507, 5/31/2022;  9143509, 5/31/2022;  9144771, 5/31/2022;  9144772, 5/31/2022;  9154934, 5/31/2022;  9155527, 5/31/2022;  9155529, 5/31/2022;  9157896, 5/31/2022;  9161567, 5/31/2022;  9162902, 5/31/2022;  9164894, 5/31/2022;  9168973, 6/30/2022;  9171622, 6/30/2022;  9172951, 6/30/2022;  9175686, 6/30/2022;  9179857, 6/30/2022;  9190047, 6/30/2022;  9191255, 6/30/2022;  9192026, 6/30/2022;  9192028, 6/30/2022;  9194258, 6/30/2022;  9196197, 6/30/2022;  9200423, 6/30/2022;  9201209, 7/31/2022;  9204095, 7/31/2022;  9204283, 7/31/2022;  9206983, 7/31/2022;  9207534, 7/31/2022;  9207913, 7/31/2022;  9208099, 7/31/2022;  9211089, 7/31/2022;  9211677, 7/31/2022;  9212097, 7/31/2022;  9213911, 7/31/2022;  9214450, 7/31/2022;  9217995, 7/31/2022;  9218456, 7/31/2022;  9218466, 7/31/2022;  9220319, 7/31/2022;  9220320, 7/31/2022;  9222097, 7/31/2022;  9222098, 7/31/2022;  9222208, 7/31/2022;  9224704, 7/31/2022;  9225074, 7/31/2022;  9225081, 7/31/2022;  9226653, 7/31/2022;  9227526, 7/31/2022;  9227930, 7/31/2022;  9228303, 8/31/2022;  9232762, 8/31/2022;  9234176, 8/31/2022;  9234899, 8/31/2022;  9235837, 8/31/2022;  9236528, 8/31/2022;  9236529, 8/31/2022;  9238869, 8/31/2022;  9239631, 8/31/2022;  9239660, 8/31/2022;  9240736, 8/31/2022;  9241927, 8/31/2022;  9242195, 8/31/2022;  9243015, 8/31/2022;  9247747, 8/31/2022;  9248036, 8/31/2022;  9250289, 8/31/2022;  9250290, 8/31/2022;  9250395, 8/31/2022;  9255902, 8/31/2022;  9256126, 8/31/2022;  9259343, 8/31/2022;  9260247, 8/31/2022;  9260249, 9/30/2022;  9261887, 9/30/2022;  9262353, 9/30/2022;  9263126, 9/30/2022;  9264104, 9/30/2022;  9264107, 9/30/2022;  9266082, 9/30/2022;  9266337, 9/30/2022;  9267130, 9/30/2022;  9267132, 9/30/2022;  9268809, 9/30/2022;  9269989, 9/30/2022;  9269991, 9/30/2022;  9270898, 9/30/2022;  9271954, 9/30/2022;  9275594, 9/30/2022;  9276137, 9/30/2022;  9276159, 9/30/2022;  9278674, 9/30/2022;  9281274, 9/30/2022;  9282883, 9/30/2022;  9283393, 9/30/2022;  9287360, 9/30/2022;  9288429, 9/30/2022;  9289665, 9/30/2022;  9290448, 9/30/2022;  9293444, 10/31/2022;  9295579, 9/30/2022;  9296389, 10/31/2022;  9296399, 10/31/2022;  9297775, 10/31/2022;  9298637, 10/31/2022;  9298640, 10/31/2022;  9301749, 10/31/2022;  9301762, 10/31/2022;  9302581, 10/31/2022;  9302586, 10/31/2022;  9303414, 10/31/2022;  9303758, 10/31/2022;  9305773, 10/31/2022;  9309480, 10/31/2022;  9309567, 10/31/2022;  9311065, 10/31/2022;  9313838, 10/31/2022;  9313839, 10/31/2022;  9316341, 10/31/2022;  9317266, 11/30/2022;  9318804, 11/30/2022;  9318806, 11/30/2022;  9319143, 11/30/2022;  9320067, 11/30/2022;  9323280, 11/30/2022;  9323406, 11/30/2022;  9324538, 11/30/2022;  9324707, 11/30/2022;  9325125, 11/30/2022;  9327963, 11/30/2022;  9329366, 11/30/2022;  9329368, 11/30/2022;  9330598, 11/30/2022;  9331805, 11/30/2022;  9338115, 11/30/2022;  9338129, 11/30/2022;  9340890, 11/30/2022;  9343956, 11/30/2022;  9343958, 11/30/2022;  9344779, 11/30/2022;  9347277, 10/31/2022;  9351555, 12/31/2022;  9353728, 12/31/2022;  9354163, 12/31/2022;  9354165, 12/31/2022;", "more_code_info": ""}, {"status": "Ongoing", "city": "New York", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88497", "recalling_firm": "Pfizer Inc.", "address_1": "235 East 42nd Street", "address_2": "", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0810-2021", "product_description": "Chantix (varenicline) tablets 1 mg, 56 Tablets, Rx only,  Distributed by Pfizer Labs, Division of Pfizer Inc. NY, NY 10017, Made in Ireland, NDC 0069-0469-56.", "product_quantity": "", "reason_for_recall": "CGMP Deviations: Presence of the N-nitroso-varenicline impurity above FDA s acceptable interim acceptable intake limit", "recall_initiation_date": "20210813", "center_classification_date": "20210917", "report_date": "20210929", "code_info": "Lots 00018777, 00019289, 00019593, 00019682, 00019846, 00019977, 00020295, 00020448, 00020458, 00020480, 00021024, 00021073, 00021074, CW1565, CW1566, CW1567, CW1568, CW1569, CW1570, CW1571, CW1572, CW1573, CW1574, CW1575, CW1578, CW1579, CW1581, DF5277, DF5278, DF5279, DF5280, DF5281, DF5282, DR5086, DR5092, DR5093, DR5094, DT3885, DW4148, DW4152, DY7987, EC9841, EC9842, EC9847, EC9848, EE1011, EM1069, EM1070, EN5694, EN5695, EP1717, EP1718, EP1719, EW2012, EW3854, EW3865, EX2102, EX2103  EXPIRATION DATE: September 2021   December 2023", "more_code_info": ""}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "134 ml", "code_info": "All lots distributed between November 2014 and May 2015;  03022015@61, 5/31/2015; 03052015@11, 6/3/2015; 04132015@21, 7/12/2015;   03242015@7, 6/22/2015; 04292015@11, 7/28/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "MEGA-BURN*  Injection, Multi-Dose Vial, Sterile, Room Temperature, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1700-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Waterford", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79149", "recalling_firm": "American Pharmaceutical Ingredients LLC", "address_1": "6650 Highland Rd Ste 302", "address_2": "N/A", "postal_code": "48327-1665", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within USA.", "recall_number": "D-0485-2018", "product_description": "Diphenhydramine HCl USP f (or prescription compounding , packaged in a) 25g ( NDC 58597-8081-4); b) 100g (NDC 58597-8081-6), RX only, packed by American Pharmaceutical Ingredients, LLC 6650 Highland Road, Waterford, MI 48327", "product_quantity": "8300 g", "reason_for_recall": "CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.", "recall_initiation_date": "20180209", "center_classification_date": "20180222", "termination_date": "20191202", "report_date": "20180228", "code_info": "Lot #: a) 031715-1, Exp. 12/31/2019; b) 031715-1, Exp. 12/31/2019"}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83669", "recalling_firm": "First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy", "address_1": "6828 E Brown Rd Ste 101", "address_2": "N/A", "postal_code": "85207-3761", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0267-2020", "product_description": "S-HYDROXOCOBA 5000MCG/ML INJ, 30ML glass vial, Red Mountain Compounding Rx", "product_quantity": "1x30 Ml glass vial", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190812", "center_classification_date": "20191105", "termination_date": "20230413", "report_date": "20191113", "code_info": "Lot#:  S05232019DT@01, Exp 8/23/19;"}]